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ABSTRACT 
Apoptosis, a form of physiological cell death, has been found to occur during 
regression of the corpus luteum (Juengel eta/, 1993; Dharmarajan eta/, 1994). 
The pathways involved in this process, however, have yet to be specified. One 
possible mediator of corpus luteum regression is the Fas (or AP0-1 or CD95) 
receptor, a transmembrane protein which induces apoptosis in the cell when 
ligated. In order to further confirm this hypolhesis, the present study 
establishes and quantitates the presence and regulation of Fas receptor and 
Fas ligand (Fasl) in the rat corpus luteum during pregnancy and post-partum. 
The animals used were sexually mature (1 0-12 week old) female Wistar rats. 
The presence of Fas and Fasl in the rat corpus luteum at various stages of 
pregnancy and post-partum was investigated by immunohistochemistry using 
an anti-Fas monoclonal antibody and an anti-FasL polyclonal antibody. FasL 
was localised in corpora lutea throughout pregnancy, whilst Fas was localised 
at day 1 of pregnancy and at the time of luteolysis. Information on the steady 
state mRNA levels of Fasl was obtained using relative quantitative reverse 
transcription PCR (RT-PCR) analysis of RNA isolated from rat ovaries at 
various stages of pregnancy and post-partum. Expression of Fasl mRNA 
increased significantly at day 22 of pregnancy, just prior to parturition, and 
decreased by day 3 post-partum. The ability of an anti-rat Fas monoclonal 
antibody to block spontaneous apoptosis in corpora lutea placed in an in vitro 
culture model with serum-free medium was examined by analysis of extracted 
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DNA using 3'-end labelling. Treatment with an anti-rat Fas monoclonal 
a11tibody demonstrated a reduction in the occurrence of spontaneous 
apoptosis. Roles for Fas receptor and Fas ligand in corpus luteum function 
were proposed, and the suitability of the in vitro corpus luteum culture model for 
future studies investigating molecular mechanisms of Fas-mediated apoptosis 
in the corpus luteum was discussed. 
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1. INTRODUCTION 
Apoptosis, a form of physiological cell death, allows tissue remodelling 
and cellular replacement to occur quickly, without damaging surrounding tissue. 
It can be distinguished from necrosis, which is cell death resulting from physical 
injury or trauma, by morphological characteristics such as cellular 
condensation, membrane blabbing, cleavage of DNA into oligomers of 185 
base pair fragments, and packaging of cellular contents into membrane-bound 
apoptotic bodies. These apoptotic bodies are phagocytosed by surrounding 
cells or macrophages. Examples of apoptotic cell death occur during 
development (Hurle, 1988; Clarke, 1990), in the elimination of autoreactive T 
and 8 lymphocytes (MacDonald and lees, 1990) and during the degradation of 
rabbit uterine epithelium following ovariectomy (Rotella et a/, 1989). 
One of the physiological processes in which apoptosis has been 
implicated is regression of the corpus luteum, an organ within the ovary which 
differentiates from the ruptured follicle following ovulation. The main function of 
the corpus luteum is secretion of progesterone, to maintain the lining of the 
uterus for implantation and for the support of a fertilised ovum. Regression of 
the corpus luteum occurs at the end of each ovarian cycle or when it is no 
longer required for the maintenance of pregnancy (Johnson and Everitt, 1995, 
pg. 71-72). little is known about the mechanisms involved in this process, 
however apoptotic cell death has been found to occur during luteal regression 
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in cattle (Juengel et a/, 1993), pseudopregnant and pregnant rabbits 
(Dharmarajan eta/, 1994; Dharmarajan eta/, 1997), pregnant rats (Ke el a/, 
1997; Sridaran el a/, 1997) and marmoset monkeys (Fraser eta/, 1995). 
As a range of stimuli may trigger apoptosis and many molecular 
pathways have been identified which facilitate apoptotic cell death, it is 
necessary to identify the mediator(s) of apoptosis in regressing luteal cells. 
One possibility is the Fas (or AP0-1 or CD95) receptor, a transmembrane 
protein which induces apoptosis in the cell following ligation. Although the 
exact mechanisms by which the Fas I Fas ligand system induce apoptosis have 
yet to be ideiiiiHed, it is known to be utilised extensively by the cells of the 
immune system (Watanabe-Fukunaga et al, 1992; Ju et a/, 1995; Dhein et a/, 
1995; Oshimi eta/, 1996). 
Within the reproductive system, the expression of mRNA for the Fas 
receptor has been detected in the mouse ovary (Watanabe-Fukunaga el a/, 
1992), and Fas appears to be involved in the regression of vaginal epithelium 
following ovariectomy and during the estrus cycle in the mouse (Suzuki et a/, 
1996). Fas receptor mRNA is also expressed by human granulosa and luteal 
cells, and Fas monoclonal antibodies can induce apoptosis in these cells when 
they are pretreated with interferon gamma in culture (Quirk et a/, 1995). In 
addition, abundant expression of the Fas receptor in the regressing corpus 
luleum of the normal adult human ovary has been reported (Kondo eta/, 1996). 
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These findings indicate that Fas-mediated apoptosis may have a role in 
the mechanisms of regression of the corpus luteum. The present study 
examined the regulation of Fas receptor and Fas ligand in the rat corpus luteum 
during pregnancy and post-partum to examine this hypothesis. AI the same 
time, the suttability of the in vitro corpus luteum culture model for future studies 
into the mechanisms of Fas-mediated apoptosis in the corpus luleum was 
assessed. 
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2. LITERATURE REVIEW 
2.1. Introduction 
Regression of the corpus luteum involves the death of considerable 
numbers of cells and significant tissue remodelling within a short period of time. 
The mechanisms contributing to luteolysis {functional and structural regression 
of the corpus luteum) are not well understood and many factors appear to 
interact to produce the changes seen in this process. Although apoptosis of 
luteal cells occurs at the time of regression, the pathways involved have yet to 
be identified. Recent studies indicate that the Fas receptor, a transmembrane 
protein capable of inducing apoptosis in the cell when ligated, is expressed by 
luteal cells at the time of regression, thus providing a rationale for further 
studies into the role of the Fas I Fas ligand system in corpus luteum function. 
2.2. The Corpus Luteum 
2.2.1. Background 
The corpus luteum, an organ within the ovary which differentiates from 
granulosa and lutein cells of the ruptured follicle following ovulation, is essential 
for successful reproduction in mammals. Its main function is secretion of the 
steroid hormone progesterone, which maintains the uterine lining in a state 
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ready for implantation and development of a fertilised ovum. Towards the end 
of each ovarian cycle or when no longer required for the maintenance of 
pregnancy, the corpus luteum undergoes functional regression, when the 
amount of progesterone secretion is dramatically reduced. This is followed by 
structural regression, with degeneration of the luteal cells. Figure 1 illustrates 
the levels of progesteron~ sncretion throughout the 23 days of rat pregnancy. 
Note that the levels are highest at around day 16 of pregnancy and they decline 
dramatically just prior to parturition. 
Whilst functional regression is necessary to allow the next ovarian cycle 
to commence, structural regression is also essential, as the ovary must rid itself 
of obsolete tissue in order to maintain its uniform size in relation to other 
organs. 
.]i 140 t g 120 
• 
8 100 ~::;sot li 60 
D: 40 
i ~~-~+-+--r~~~-+_,--r-~~ 
0 1 3 5 7 9 11 13 15 17 19 21 23 
Day of Pregnancy 
FIGURE 1: Serum Levels of Progesterone Throughout Rat Pregnancy 
(SOURCE: Uchida et al, 1970) 
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2.2.2. The Rat Estrus Cycle 
The following section outlines the nature of the estrus cycle and 
histology of the rat corpus /Uteum, as natural regression of the pregnant rat 
corpus /Uteum was the model used for this study. 
The estrus cycle of the rat generally lasts for four days and comprises 
four stages. Proestrus is characterised by the rapid growth of follides and 
regression of corpora lutea from the previous cycle. The follicles then grow to 
their maximum size during estrus. Ovulation occurs early in the next stage, 
metestrus. In the latter part of this stage new corpora lutea are formed from 
differentiated granulosa and lutein cells of the ovulated follicles. During 
diestrus, the newly formed corpora lutea and follicles for the next cycle grow 
(Hebel and Stromberg, 1986, pg. 231 ). 
Corpora lutea from previous cycles regress slowly in the rat, so that 
three or more generations can be seen in the ovary at any time during a 
specific estrus cycle (Hilliard, 1973). After several cycles the corpora lutea 
involute, form scar tissue which is known as corpora albicans, and eventually 
disappear. Figure 2 depicts a whole ovary from a rat at day 22 of pregnancy 
and the histology of the rat ovary. Individual corpora /Utea which have been 
dissected from a rat ovary and the histology of the corpus luteum are shown in 
Figure 3. 
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The gestation time in rats is 23 days, with the corpus luteum reaching 
maximum function at day 16 of pregnancy, as illustrated in Figure 1. Functional 
regression of the corpus luteum, evidenced by a decrease in progesterone 
secretion, begins two to three days before parturition. The number of luteal 
cells in the rat corpus luteum stays constant (Meyer and Bruce, 1979; 
Dharmarajan et a/, 1989), indicating that cell death does not occur at this time. 
Structural regression of luteal cells becomes apparent at day 1 post-partum and 
the weight of the corpus luteum of pregnancy continues to decline over 
numerous estrus cycles following parturition (Taya and Greenwald, 1982). 
s 
F 
CL 
CL 
(a) (b) 
FIGURE 2: The Rat Ovary 
(a) Whole Ovary From a Rat at Day 22 of Pregnancy. 
(b) Section of Rat Ovary Stained with Haematoxylin and Eosin, 
1 Ox. CL- Corpus Luteum, F - Follicle, S - Stroma. 
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(a) 
FIGURE 3. The Rat Corpus Luteum 
(a) Individual Corpora Lutea Dissected from a Rat Ovary at 
Day 22 of Pregnancy. 
(b) Section of Rat Corpus Luteum Stained with Haematoxylin 
and Eosin, 40x. Arrows - Luteal Cells, Arrowheads -
Endothelial Cells. 
2.2.3. Proposed Mechanisms of Corpus Luteum Regression 
Hormonal influences in luteolysis differ from species to species and are 
not well characterised. The reduction in progesterone secretion prior to 
luteolysis has been attributed to secretion of prostaglandin F2a. in the sheep, 
cow, guinea-pig and horse (Johnson and Everitt, 1995, pg. 72), however a 
similar signal in other mammals has not been identified. Thus, luteolysis in 
some species may be initiated by withdrawal or insufficient supply of 
luteotrophic substances, whilst in others luteolysis follows the release of a 
luteolytic substance. The matter is further confused by .evidence that some 
luteotrophic hormones may have luteolytic properties, either through an age 
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dependent differential reaction by the luteal cells, or when in combination with 
other hormones (Hilliard, 1973). 
Whatever the initial hormonal influence, regression of the corpus luteum 
is a cyclic event which occurs in all mammals. Cellular and molecular 
mechanisms proposed to be involved in luteal cell regression (Juengel et a/, 
1994) include: 
(1) reduction of blood flow, 
(2) formation of oxygen radicals, and 
(3) infiltration of immune cells. 
Reduction of blood flow to the corpus luteum at the time of regression 
could be expected to have a role in luteolysis, by diminishing the amounts of 
luteotrophic substances available to luteal cells. Rates of blood flow in relation 
to functional regression of the corpus luteum have been investigated by many 
researchers using various animals and models of regression, with variable 
results reported (Bruce et a/, 1984). In the rat, blood flow to the corpus luteum 
did not appear to be reduced in natural regression at the end of 
pseudopregnancy (Pang and Behrman, 1979) or pregnancy (Bruce eta/, 1984). 
Nor was it reduced by prostaglandin-induced regression (Pang and Behrman, 
1981). Furthermore, examination by light microscopy showed no evidence of 
vascular degeneration during natural regression of the pregnant rat corpus 
luteum (Bruce eta/, 1984). Thus blood flow does not appear to be a significant 
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factor in corpus luteum regression in the rat (Bruce el a/, 198~' although it may 
have a role in luteolysis in other species. 
Oxygen radicals and reactive oxygen species are highly charged and/or 
reactive products of physiological chemical processes produced in cells during 
aerobic metabolism. They are capable of causing damage to tissue due to their 
highly reactive nature. Consequently, cells have developed defence 
mechanisms, such as antioxidant enzymes. Research indicates, however, that 
oxygen radicals and reactive oxygen species assist in a variety of reproductive 
functions, including capacitation (a process involving plasma membrane 
changes to spermatozoa so that they are able to fertilise an ovum), the binding 
of spemn to the zona pellucida of the ovum, and ovulation (Riley and Behrman, 
1991). Small amounts of hydrogen peroxide, a reactive oxygen species, have 
been shown to exert luteolytic effects on rat ovarian cells (Behrman and 
Preston, 1989). Also, production of hydrogen peroxide rapidly increases in rat 
ovaries during the natural luteal regression that occurs in late 
pseudopregnancy, and in regression induced by treatment with prostaglandin 
F,. (Riley and Behrman, 1991), further indicating a role in luteolysis. 
As granulosa cells do not differentiate into luteal cells until the onset of 
sexual maturation, luteal tissue Is not present during the time that the immune 
system is adapting to "self'. This unique characteristic of the corpus luteum has 
led to the proposal that immune mechanisms may be involved in corpus luteum 
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regression (Bukovsky et at, 1995), and numerous studies indicate that the 
immune system may have a role in luteolysis. Bukovsky et a/ found in 1977 
(cited in Bagavandoss et at, 1990) that existing corpora lutea persisted in adult 
rats treated with antithymocyte serum. Both macrophages and activated T 
lymphocytes were present in the rabbit corpus luteum throughout the luteal 
phase, with the number of macrophages increasing significantly during the 
latter stages of regression, both in pseudopregnancy and following parturition 
(Bagavandoss et at, 1990). Further, Class II major histocompatibility complex 
(MHC) antigens, which activate T lymphocytes when presented by cells in 
conjunction with antigens that trigger immune responses, have been identified 
in: 
• human granulosa cells with autoimmune dysfunctiOn (Hill el at, 1990), 
• cultured bovine luteal cells treated with interferon gamma (Fairchild and 
Pate, 1989), 
• bovine large luteal cells, increasing throughout the estrus cycle to reach a 
maximum before luteolysis (Fairchild Benyo et at, 1991), 
• the rat corpus luteum during pregnancy and pseudopregnancy, increasing at 
the time of luteolysis (Branstrom et at, 1994), and · 
• human granulosa lutein cells, substantially increasing during the late luteal 
phase (Bukovsky et a/, 1995). 
Fairchild Benyo et a/ (1991) hypothesised that the expression of Class II MHC 
antigens on luteal cells potentiates immune responses involved with luteolysis. 
Whilst T lymphocyte infiltration of the corpus luteum did not appear to ~Iter 
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significantly throughout the luteal phase in rats (Branstrom et al, 1994), these 
cells were present in the regressing corpus luteum of the rabbit (Bagavandoss 
eta/, 1988), and human (Bukovsky el a/, 1995). Thus, from research to dale, 
immune cells do appear to have a role in corpus luteum function which could be 
related to a reduction in progesterone secretion and/or luteolysis. 
It is important to note that each of the above proposed mechanisms 
involved in luteal regression are not mutually exclusive. Indeed, immune 
mechanisms could possibly lead to vascular degeneration and increased 
concentrations of oxygen radicals. The apoptosis which occurs during 
luteolysis may be triggered by one, or a combination, of these factors or by 
conditions yet to be identified. 
2.3. Apoptosis 
2.3.1. Background 
Since the advent of the cell theory in the nineteenth century, scientists 
have known that all cells must eventually die. Before the early 1970's, 
however, most research into cell death focused either on necrosis, cell death 
resulting from physical insults, such as trauma, infectious agents and exposure 
to toxins, or on the mechanisms of ageing. The significance of physiological 
cell death was not fully realised until after the process was characterised 
morphologically by Kerr eta/ (1972). This regulated process of cell death was 
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named apoptosis from the Greek word for falling (as does a leaf from a tree), 
referring to detachment of the dying cells from the extracellular matrix. 
Apoptosis is necessary for normal function in organisms as it allows 
tissue remodelling and cellular replacement to occur quickly will! little or no 
damage to surrounding cells. It is also a pathway which may be taken by cells 
which have been significantly, but not fatally, damaged by physical insult. 
Examples of apoptotic cell death occur during development (Hurle, 1988; 
Clarke, 1990), in the elimination of autoreactive T and 8 lymphocytes 
(MacDonald and lees, 1990; Sambhara and Miller, 1991), during the 
degradation of endometrial cells (Rotella et a/, 1989), and in cytotoxic T 
lymphocyte-mediated killing of target cells (Cohen eta/, 1985). 
Cell death by apoptosis follows from a range of stimuli or from the 
withdrawal of growth factors. Depending on the cell type and stimuli, apoptotic 
cell death may occur by a variety of molecular pathways, however, the 
observed morp:1ological characteristics are generally uniform. Induction 
involves the activation of specific proteins which function in various aspects of 
this process. Occurring in single cells or small clusters of cells, apoptosis is 
characterised by cellular condensation, membrane blebbing, cleavage of DNA 
into oligomers with multiples of 185 base pair fragments (the DNA is cleaved at 
internucleosomal sites), and packaging of cytoplasmic and nuclear contents 
into membrane-bound vessels known as apoptotic bodies. Surrounding cells or 
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macrophages phagocytose these apoptotic bodies, preventing the release of 
harmful cellular contents in the extracellular matrix. 
Identification and confirmation of apoptotic cell death can be wovided by 
a variety of methods. Those most commonly used include the observation of 
morphological characteristics, 3'-end labelling, in situ labelling of double strand 
DNA breaks with terminal deoxynucleotidy/ transferase-mediated dUTP biotin 
nick end-labelling (TUNEL), and the comet assay. Tl,3 morphology of dying 
cells can be viewed by light or electron microscopy. As stated previously, 
features which distinguish apoptotic cells from necrotic cells include the 
presence of cellular condensation, chromatin condensation, membrane 
blebbing and the production of apoptotic bodies. By comparison, cells dying by 
necrosis are evidenced by cellular swelling, lysis of the cells and the presence 
of inflammation in the surrounding tissue. Viewing the morphology of cells is an 
important and useful tool to confirm apoptotic cell death in the tissue of interest, 
as cell types and locations can be identifled. This technique, however, is not a 
practical choice for use in quantitative studies, as morphological characteristics 
of apoptosis may only be seen in a small number of cells at any one time and 
cell counting methods are lime-consuming. 
Both 3'-end labelling and TUNEL involve labelling of DNA which has 
been fragmented. DNA extracted from tissue is used for 3'-end labelling, where 
the 3'-ends of cleaved DNA are labelled with a radioactive nucleotide (a"P-
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ddATP). The labelled DNA is fractionated on an agarose gel from which an 
autoradiograph is developed. DNA from cells undergoing apoptosis show 
ladders with multiples of around 185 base pairs in size, indicating that the DNA 
has been cleaved at intemucleosomal sites, while DNA from necrotic cells is 
characterised by a smear, indicating the random breakdown of genetic material 
which occurs in this type of cell death (Tilly and Hsueh, 1993). The 3'-end 
labelling technique is a useful tool for quantitative analysis of the extent of 
apoptosis, as the low molecular weight DNA bands from each lane in an 
agarose gel can be excised and counts per minute obtained from a scintillation 
counter. This method, however, cannot confirm which cell types in tissue 
samples are dying by apoptosis. On the other hand, TUNEL does allow the 
identification of which cells are dying, but does not distinguish between 
apoptosis and necrosis (Hsueh el a/, 1994). The comet assay involves 
electrophoresis of cell preparations to draw charged DNA from the cell nucleus 
(Fairbairn el a/, 1995). Fragmented DNA forms a characteristic "comet-like" tail 
as it migrates further than intact DNA, and so apoptotic cells can be rapidly 
identified (Fairbairn el at, 1995). Two methods of detection are often used in 
tandem, in order to balance the relative advantages and disadvantages of 
each. 
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2.3.2. Apoptosis and the Reproductive System 
The reproductive system provides many examples of physiological 
processes which require extensive tissue remodelling and cell death during 
normal function. Thus, it is not surprising that the occurrence of apoptosis has 
been confirmed in various reproductive cell types undergoing regression and 
attrition. Numerous studies of the relationships between hormone-dependent 
cells and apoptosis have been conducted. 
In the male, apoptosis was found to occur in the ventral lobe of the rat 
prostate gland following the post-castration cessation of testosterone secretion 
(Kyprianou and Isaacs, 1988). The rat prostate has since been developed as 
an in vivo model for studying molecular mecha~isms of apoptosis, as a 
considerable number of cells undergo apoptosis and the length of time taken 
for the ventral prostate cells to die is predictable (Colombe! and Buttyan, 1995). 
Apoptosis has also been implicated in the deletion of germ cells during 
normal spermatogenesis. Up to 75% of the potential number of mature sperm 
which can be produced from germ cells in the adult testis are lost (Billig et at, 
1996). The morphological characteristics observed in spermatogonial cell 
death are the same as those described in cells undergoing apoptosis (Allan et 
at, 1992). Depletion of testosterone and gonadotropin by administration of an 
antagonist to gonadotropin-releasing hormone was associated w~h a significant 
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increase in apoptosis of germ cells, as detected by 3'-end labelling and TUNEL 
(Hikim eta/, 1995; Brinkworth eta/, 1995). A role for apoptosis in prenatal male 
gonads has also been suggested, with the identification of apoptotic 
morphology in embryonic germ cells of the male mouse (Coucouvanis et a/, 
1993). Follicle stimulating hormone (FSH) has been shown to influence the 
survival of germ cells in both immature and adult rats, with apoptosis (again 
evaluated by 3'-end labelling and TUNEL) increasing when FSH was 
specifically immunoneutralised (Shelly et a/, 1996). Further, in samples of 
semen collected from a human fertility centre, a correlation was found between 
the percentage of sperm cells which showed characteristics associated with low 
fertility and the percentage of sperm cells which stained posttive for DNA strand 
breaks using TUNEL (Gorczyca et a/, 1993). The authors concluded that 
apoptosis may be involved in the physiological deletion of germ cells, possibly 
to eliminate defective cells (Gorczyca et a/, 1993), however, other detection 
methods for apoptosis would need to be used to confirm this suggestion. 
Apoptosis has also been found to occur in the female reproductive 
system and, as in the male, hormonal control does appear to influence 
physiological cell death in some situations. Ovariectomy, for example, results 
in apoptosis of uterine epithelial cells in rabbits (Rotello eta/, 1989). 
One of the most striking examples of tissue loss over time occurs in the 
ovaries of mammals. Before the onset of ovulation, 99.9% of the follicles 
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present in human ovaries at birth degenerate by a process known as atresia 
(Hsueh eta/, 1994). In 1991, Hughes and Gorospe showed by identification of 
morphological characteristics and use of 3'-end labelling that rat granulosa cells 
of follicles induced to degenerate appear to undergo apoptosis. Similar findings 
were published by Tilly eta/ in the same year with naturally atretic chicken and 
porcine follicles. Hormones were found to control apoptosis in granulosa cells, 
with oestrogens preventing apoptosis and testosterone negating the effects of 
oestrogens (Billig eta/, 1993). Whilst Billig eta/ (1993) found that progesterone 
had no effect on granulosa cell apoptosis, Peluso and Pappalardo (1994) 
reported that progesterone reduced the incidence of apoptosis in cultured rat 
granulosa cells and, further, that adhesion between cells enhanced the anti-
apoptotic effects of progesterone. 
2.3.3. Apoptosis in the Corpus Luteum 
The first molecular evidence that luteal cells may undergo apoptosis was 
presented by Zeleznik et a/ (1989). Similartties in descriptions of the 
histological changes occurring in the corpus luteum during the luteal phase of 
pregnancy (Corner, 1956), and the cellular changes associated with apoptosis 
(Kerr eta/, 1972), prompted Zeleznik eta/ (1989) to investigate the occurrence 
of apoptotic degeneration in luteal cells. As stated previously, one of the 
characteristics of apoptosis is the cleavage of DNA into oligomers of 185 base 
pairs. Cohen and Duke (1984) identified an endonuclease capable of 
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fragmenting DNA in this manner, so Zeleznik et a/ (1989) searched for, and 
detected, Ca"/Mg"-dependent endonuclease activity in differentiated rat 
granulosa cells, but not in undifferentiated gransulosa cells. Interestingly, a 
calcium ionophore had been shown to mimic the luteolytic effects of 
prostaglandin F 2, (PGF ,,) in isolated luteal cells (Baum and Roseberg, 1977), 
perhaps because ~ activated an endonuclease responsible for DNA cleavage in 
apoptosis. 
That luteal cells were actually capable of dying by apoptosis was initially 
confirmed by Juengel eta/ (1993). In both spontaneous and PGF,,-induced 
luteal regression in cattle, apoptosis, detected by fractionating DNA on an 
ethidium bromide-stained agarose gel or 3'-end labelling, occurred after 
progesterone serum levels had begun to decrease. Hence, Juenger et a/ 
(1993) proposed that apoptosis was instrumental during structural regression of 
the corpus luteum but not during functional regression. This study also found 
that capillaries within the corpus luteum disappeared before fragmented DNA 
could be detected, indicating that endothelial cells were not undergoing 
apoptosis at the time of structural regression of luteal cells. II is possible that 
the decrease in progesterone secretion by luteal cells, or the disappearance of 
endothelial cells in the corpus luteum, may be early triggers leading to the 
apoptotic cell death seen in structural regression in cattle (Juengel eta/, 1993). 
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In contrast, a correlation between the occurrence of apoptosis and 
functionalluteolysis in the pseudopregnant and pregnant rab~it ovary has been 
found (Dharmarajan eta/, 1994; Dharmarajan eta/, 1997). An analysis of DNA 
integrity by TUNEL confirmed that those cells undergoing DNA fragmentation 
were luteal cells (Dharmarajan eta/, 1994). The in vitro corpus luteum culture 
model was developed following the discovery that spontaneous apoptosis 
occurred in rabbit corpora lutea cultured in serum-free medium. This model 
was used to show that treatment with human chorionic gonadotropin, the 
hormone which sustains luteal function during the first trimester of pregnancy in 
humans, could suppress apoptosis in cultured rabbit corpora lutea 
(Dharmarajan eta/, 1994). 
Recently, in vivo treatment of rat corpora lutea with a gonadotropin-
releasing hormone agonist during early pregnancy was found to induce 
apoptosis in luteal cells (Sridaran et a/, 1997). The same study found that 
spontaneous apoptosis of luteal cells could be induced by culturing rat corpora 
lutea in serum-free medium (Sridaran eta/, 1997). An analysis of DNA integrity 
by TUNEL indicated that some apoptosis is occurring at day 22 of rat 
pregnancy, increasing by day 1 post-partum (Ke eta/, 1997). 
Corpora lutea of marmoset monkeys undergoing induced regression 
following administration of either a PGF,. analogue or gonadotropin-releasing 
hormone antagonist, showed morphological features in some degenerating 
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luteal cells which were characteristic of apoptosis, whilst other luteal cells 
appeared to be dying by necrosis (Fraser eta/, 1995). Unfortunately, further 
experiments to confirm that apoptotic cell death was occurring, and to identify 
the extent of apoptosis, were not undertaken. 
In summary, apoptosis has been found to occur during luteolysis in a 
range of mammalian species. The mechanisms and pathways involved in 
apoptotic cell death in the corpus luteum, however, have yet to be identified. 
2.4. The Fas I Fas Ligand System 
As stated in the previous section, the molecular pathway by which 
apoptosis occurs is dependent upon the cell type involved and the stimuli 
received. Thus, luteal cells undergoing apoptosis may use one of many 
pathways, or perhaps more than one pathway, during regression. One possible 
mediator involved in corpus luteum regression is the Fas (or AP0-1 or CD95) 
receptor, a transmembrane protein which induces apoptosis in the cell when 
ligated. 
2.4.1. Background 
In 1989 two separate research groups developed mouse monoclonal 
antibodies, named Fas (Yonehara eta/, 1989) and AP0-1 (Trauth eta/, 1989), 
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which were capable of inducing apoptosis in some human cell lines. The 
cytolytic activity was particularly apparent when the cells were also treated with 
interferon gamma (Yonehara el a/, 1989). These antibodies had two possible 
modes of action: they either bound to an antigen which was a receptor with 
cytolytic activity and acted as a ligand by inducing apoptosis, or the antibodies 
bound to an antigen which was a receptor for a growth factor or a molecule 
essential for transduction of a growth signal, blocking the signal and causing 
cell death. Expression of human Fas eDNA in mouse cell lines made the cells 
susceptible to death induced by the Fas monoclonal antibody, indicating that 
the Fas receptor did transduce an apoptotic signal to the cell (Itch el a!, 1991). 
The Fas receptor was classified as a type I membrane protein (because the N-
terminal of the protein was extracellular and the C-terminal lay within the cell), 
belonging to the tumour necrosis factor (TNF) receptor family. This grouping 
includes TNF receptor I (also capable of inducing cell death) and II, nerve 
growth factor receptor and lymphocyte antigens such as CD40 and OX40 (Itch 
eta/, 1991). Subsequently, the Fas and AP0-1 antibodies were found to act 
upon the same receptor (Oehm el a/, 1992). 
Fas antigen mRNA expression was detected in the mouse thymus, 
heart, liver and ovary (Watanabe-Fukunaga el a/, 1992), indicating that it was 
possibly involved in a variety of apoptotic processes. Deletion of a region at the 
C-terminus of Fas showed that this area was necessary for the transduction of 
cytolytic activity (Itch and Nagata, 1993). Homology to the TNF receptor I was 
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significantly conserved in this region and the 68 constituent amino acids were 
termed the "death domain", highlighting their function in transducing an 
apoptotic signal to the cell (ltoh and Nagata, 1993). 
Fas ligand, cloned in 1993, was found to be a type II transmembrane 
protein belonging to the TNF family (Suda ef a/, 1993). The structure and 
properties of Fas ligand were similar to those of TN Fa (for example, Fas ligand 
appeared to function as a trimer and overexpression of the protein resulted in 
shedding of a soluble form which was capable of inducing apoptosis), but Fas 
ligand specifically activated the Fas receptor (Suda et at, 1993). Fas ligand 
mRNA expression in the rat was detected in spleen, testis, small intestine, 
kidney and lung (Suda eta/, 1993). 
As Fas and TNF had many similarities, Clement and Stamenkovich 
(1994) compared the two by transfecting fusion proteins consisting of the 
extracellular region of CD40 and the transmembrane. and intracellular regions of 
Fas receptor, TNF I receptor or TNF II receptor into a human melanoma cell 
line which did not express these proteins. Cells were treated with the CD40 
ligand and differences in the rates of cell death examined. While Fas receptor 
was capable of killing most cells within hours, the TNF receptors required two to 
three days of treatment with the CD40 ligand for cytotoxicity to occur (Clement 
and Stamenkovich, 1994), indicating either that different molecular mechanisms 
were involved in the induction of apoptosis or that the TNF receptors induced 
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apoptosis following a convoluted series of steps, whilst Fas-metJiated apoptosis 
directly and immediately triggered the cell death pathway. 
2.4.2. Fas and Fas Ligand in the Immune System 
In the few short years since the Fas/Fas ligand system was discovered 
and characterised many important functions within the immune system have 
been shown to involve Fas-mediated apoptosis. The physiological significance 
of Fas expression in the thymus was first realised when it was found that mice 
carrying the lymphoproliferation (lpr) mutation had defects in the gene for Fas 
receptor (Watanabe-Fukunaga et a/, 1992). Lymphoproliferation disorder in 
mice resembles human systemic lupus erythematosus and is characterised by 
lymphadenopathy, splenomegaly, production of many autoantibodies and the 
development of nephritis or arthritis (Watanabe-Fukunaga eta!, 1992). Further 
evidence for this proposal was presented when generalised lymphoproliferative 
disease (gld) in mice, also characterised by lymphadenopathy and 
splenomegaly, was found to result from a point mutation in the gene coding for 
Fas ligand (Takahashi eta!, 1994). The phenotypes' indicate that Fas-mediated 
apoptosis is used in the thymus to delete negatively selected T cells which 
react to "selF antigens. 
T-cell mediated cy1otoxicity, previous!)• thought to result only from 
formation of perforin pores in target cells, can occur by the Fas/Fas ligand 
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system. Fas-mediated apoptosis of target cells was. demonstrated by cytotoxic 
T lymphocytes incapable of killing using perforin pores (Kagi et a/, 1994). 
Target cells from lpr mutant mice, however, could not be killed by these T cells 
(Lewin eta/, 1994). Thus, cytotoxic T lymphocytes are capable of expressing 
Fas ligand in order to induce apoptosis in target cells which express the Fas 
receptor. More recently, human natural killer cells have also been shown to be 
capable of inducing apoptosis in target cells by expression of Fas ligand 
(Oshimi eta/, 1996). 
As both lpr and gld mice showed defects in the deletion of peripheral 
activated T cells, a role for Fas in inducing apoptosis of activated T cells for 
immune suppression was proposed (Dhein et a/, 1995; Ju et a/, 1995). 
Activated T cells increased the expression of Fas receptor mRNA (Dhein et a/, 
1995) and markedly increased the expression of Fas ligand mRNA (Ju et a/, 
1995). Also, the death of activated T cells could be prevented by treating cells 
with an antibody capable of blocking Fas-mediated apoptosis (Dhein et a/, 
1995; Ju eta/, 1995). 
In summary, Fas-mediated apoptosis has been shown to have significant 
roles in immune system function, including deletion of self-reactive T 
lymphocytes in the thymus, T cell- and natural killer cell-mediated cytotoxicity 
and immune suppression of activated T cells. 
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2.4.3. Fas Ligand and Immune Privilege 
The ability of some tissue sttes to protect grafted tissue from rejection 
and of some tissue types to be grafted wtthout being rejected is known as 
immune privilege. Attacks by the immune system in response to foreign 
antigens invariably result in damage to surrounding tissue and inflammation. In 
delicate or non-dividing tissue, as is found in the eye" and brain, the effect of the 
cure may be worse than the cause. Also, in the case of pregnancy, foreign 
tissue must be accepted for successful reproduction. Protection from damaging 
immune reactions is achieved by a variety of physiological means, including 
blood-tissue barriers and immune suppression. 
The expression of Fas ligand to facilitate the killing of activated T cells 
displaying the Fas receptor has been proposed as another mechanism of 
immune privilege (Bellgrau et a/, 1995; Griffith et a/, 1995). In confirmation, 
Sertoli cells of the testis express Fas ligand and are able to survive indefinitely 
when transplanted in the kidney capsule of allogeneic animals, whilst Sertoli 
cells from gld mice (which express non-functional ligand) are rejected (Bellgrau 
eta/, 1995). Further, Griffith eta/ (1995) performed a series of experiments 
implicating Fas ligand-mediated immune privilege in the mouse eye. Both Fas 
ligand mRNA and protein were expressed in the eyes of normal mice. 
Inflammatory cells entering the anterior chamber of the eye in normal mice, but 
not in gld mice, died. No immune response was detected in the virally infected 
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eyes of normal mice, whereas gld mice exhibited inflammation and survival of 
immune cells in similarly infected eyes. Also, Fas-positive tumour cells died 
when exposed to isolated anterior segments of the eye in normal mice but not 
in gld mice, and Fas-negative tumour cells did not die (Griffith eta/, 1995). 
Unfortunately, the mechanism(s) of cell death were not confirmed as being 
apoptosis, as the authors analysed DNA fragmentation by TUNEL alone. 
Fas ligand has also been detected in human cytotrophoblasts of first 
trimester placental tissue sections and syncytiotrophoblasts of term placenta by 
immunohistochemical staining and Western blotting, indicating that its 
involvement in immune privilege may also extend to protection of the foetus 
(Runic eta/, 1996). 
2.4.4. Fas and Fas Ligand in the Reproductive System 
Fas and Fas ligand mRNA and protein is. expressed in a range of 
reproductive tissues (Watanabe-Fukunaga et al, 1992; Suda et a/, 1993; 
Bellgrau et a/, 1995; French et a/, 1996). Examination of their role in these 
tissues, however, has only recently begun. 
Steroid hormones such as testosterone, oestrogen and progesterone are 
essential for normal reproductive functioning, not least because of their role in 
the regulation of cell proliferation. Removal of the gonads (and, therefore, 
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cessation of testosterone secretion) in the normal male mouse resulted in 
expression of F as receptor and apoptotic regression of the prostate and 
epididymis, whilst no regression was observed following gonadectomy of lpr 
mice (Suzuki, Matsuzawa and Iguchi, 1996). Similarly, Fas expression was 
increased and apoptotic cell death confirmed during ovariectomy-induced 
regression of normal mouse vaginal epithelial cells, but changes were not 
detected in lpr mice (Suzuki, Enari, Eguchi, Matsuzawa, Nagata, Tsujimoto and 
Iguchi, 1996). 
Abundant expression of Fas receptor in regressing corpora lutea and 
atretic follicles of humans, as well as decreasing expression of Fas receptor in 
maturing oocytes has been detected using immunohistochemistry (Kondo el a/, 
1996). Confirmation of these findings was provided by Quirk eta/ (1995) who 
found that Fas mRNA was expressed by human granulosa /luteal cells. This 
study also showed that cultured granulosa I luteal cells pretreated with 
interferon gamma were capable of undergoing apoptosis induced by a Fas 
monoclonal antibody (Quirk el a/, 1995). 
2.5. Summary 
The molecular mechanisms involved in regression of the corpus luteum, 
an essential process in the female reproductive system, are not well 
understood. Although apoptosis has been shown to occur during luteolysis 
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(Juengel et at, 1993; Dharmarajan eta/, 1994; Fraser eta/, 1995; Dharmarajan 
eta/, 1997; Sridaran et at, 1997; Ke et at, 1997), the pathway(s) leading to cell 
death have yet to be identified. Fas mRNA is expressed by human granulosa 
and luteal cells, and Fas monoclonal antibodies are able to induce apoptosis in 
these cells when they are pretreated with interferon gamma in culture (Quirk et 
a/, 1995). In addition, abundant expression of the Fas receptor in the 
regressing corpus luteum of the normal adult human ovary has been reported 
(Kondo et at, 1996). Further studies are required to examine the regulation of 
both Fas receptor and Fas ligand in the naturally regressing corpus Juteum, and 
to clarify the role of the FastFas ligand system in corpus luteum function. 
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3. ANIMALS 
Throughout the research the experimental animals used were sexually 
mature (10-12 week old) female Wistar rats. They were housed at 21•c with 
55% humidity in a 12 hours light I 12 hours dark cycle. The feed was 
autoclaved nonmal cubes and acidified water, both provided ad lib. 
3.1. Mating and Gestation 
Five female rats were caged with one male rat overnight to allow mating 
to occur. Day 1 was taken to be the day after successful mating. Rats were 
considered to be pregnant if sperm were present in a vaginal smear on Day 1. 
The gestation time for rats is 23 days (ie: the litter is born on day 23 of 
pregnancy). Table 1 shows the various pregnancy and post-partum stages 
used throughout this study. 
Table 1 
Stages of Pregnancy and Post Partum in the Rat used for this Study 
STAGE 
Day 1 
DayS 
Day 16 
Day22 
Post-Partum Day 1 
Post-Partum Day 3 
ABBREVIATION 
D1 
DB 
D16 
D22 
PP1 
PP3 
DESCRIPTION 
The day after successful mating 
8 days after successiul mating 
16 days after successful mating 
22 days after successful mating 
1 day after birth of litter 
3 days after birth of litter 
38 
3.2. Tissue Collection 
Rats were heavily anaesthetised with a mixture of halothane and nitric 
oxide during the procedure. Ovaries and portions of spleen were excised as 
quickly as possible and treated as required for the particular protocol b be 
followed (either immunohistochemistry, RT-PCR or organ culture). After the 
removal of tissue, rats were killed by administration of a lethal dose of 
anaesthetic. 
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4. IMMUNOHISTOCHEMISTRY 
4.1. Rationale 
Immunohistochemistry is an established, routine histological technique 
used to identify antigens in tissue sections by means of antigen reaction with a 
labelled primary or secondary antibody (Robinson et a/, 1990, pg. 413). Not 
only can the presence of Fas and Fas ligand be confirmed using this technique, 
but the proteins can also be localised to particular cells in tissue sections. 
Antibodies, which belong to a group of proteins called immunoglobulins, 
are produced by B lymphocytes to bind selectively to foreign antigens. The 
region on the antigen to which the antibody binds is known as an epitope. 
There are an almost infintte number of antibodies which can be made, but 
individual B lymphocytes can only make one specific antibody. When launching 
an immune attack, a B lymphocyte is able to proliferate, forming clones which 
all secrete the same specific antibody. 
Antibodies produced for immunohistochemistry may be either 
monoclonal or polyclonal. Monoclonal antibodies are produced by clones of 
one B lymphocyte, so they bind with one specific epitope on an antigen. 
Polyclonal antibodies are made by clones of different B lymphocytes which 
react to a specific antigen, so they bind to a variety of epitopes on the one 
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antigen (see Figure 4). As monoclonal antibodies bind to only one epitope, 
there is less chance of non-specific binding or cross-reactivity compared to 
polyclonal antibodies. However, if the epitope is. concealed by tissue fixation no 
binding can occur, whilst polyclonal antibodies can bind to various epitopes 
which may not have been concealed on the antigen. Also, the time and cost 
involved in producing monoclonal antibodies is much higher than for polyclonal 
antibodies. 
Antigen 
Epitopes • e 
• 
Antibody 
(a) (b) 
FIGURE 4: Monoclonal and Polyclonal Antibody Binding 
(a) Monoclonal antibodies bind to a specific epitope on an 
antigen. 
(b) Polyclonal antibodies bind to various epitopes on an 
antigen. 
A variety of protocols have been developed for the detection of bound labelled 
antibodies. lmmunoenzymatic staining using the enzyme horse radish 
peroxidase and the chromogenic substrate 3'3'-diaminobenzidine 
tetrahydrochloride (DAB) was chosen for both the Fas receptor and Fas ligand. 
The reaction between horse radish peroxidase and DAB in the presence of 
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hydrogen peroxide produces a brown end product which is stable and can be 
viewed by light microscopy. 
The two-step indirect method of immunoenzymatic staining was used to 
detect Fas receptor in tissue sections (see Figure 5). After incubation with the 
unlabelled primary antibody (mouse anti-rat Fas monoclonal antibody), a horse 
radish peroxidase-labelled secondary antibody directed against the primary 
antibody was applied. As the primary antibody was produced in the mouse, the 
secondary antibody chosen bound with mouse immunoglobulins. The section 
was then incubated with DAB and hydrogen peroxide to produce the coloured 
end product. 
~ KEY Antigen 
-~ )~ Primary Antibody )~ 
Enzyme Labelled ~ 
Secondary Antibody r-
FIGURE 5: Two-Step Indirect Method of lmmunoenzymatic Staining 
A labelled avidin-biotin technique was used to detect the presence of Fas ligand 
(see Figure 6). This method utilises the high affinity between avidin or 
streptavidin and biotin. After the unlabelled primary antibody (goat anti-rat Fas 
ligand polyclonal antibody) was applied, sections were incubated with the 
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secondary antibody, which was biotinylated (covalently bound to biotin). As the 
primary antibody was produced in the goat the secondary antibody chosen 
bound with goat immunoglobulins. Streptavidin labelled with horse radish 
peroxidase was then applied to sections to bind with the biotin on the secondary 
antibody, and DAB and hydrogen peroxide were applied to produce the 
coloured end product. 
KEY 
~ Antigen 
-
r-
Primary Antibody )~ J~ Biotinylated Secondary ~ Antibody ,f"T 
Streptavidin Horse 
'd Radish Peroxidase 
FIGURE 6: Labelled Avidin-Biotin Method of lmmunoenzymatic Staining. 
The Fas antigen has previously been localised in the human ovary using 
the avidin-biotin immunoperoxidase method (Kondo et a/, 1996). It is 
necessary, however, to confirm the presence and localisation of both Fas 
receptor and Fas ligand at the time of corpus luteum regression, as both are 
required for induction of Fas-mediated apoptosis. Thus, the present study was 
designed to examine patterns in staining of corpora lutea at the same stage of 
pregnancy and post-partum, as well as at different stages. It was also planned 
that a comparison of results for Fas receptor and Fas ligand would be made. 
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4.2. Sample and Tissue Preparation 
For the study, four rats from each stage of pregnancy and post-partum 
(i.e. days 1, 8, 16 and 22 of pregnancy and days 1 and 3 post-partum) were 
required, and one ovary from each rat was used. Portions of spleen were 
excised from rats for use as positive controls. Following excision, the ovaries 
and portions of spleen were fixed in 4% paraformaldehyde at 4'C for 24 hours. 
They were then kept in phosphate buffered saline (PBS) at 4 'C until 
processing. Tissue was processed using a Shandon Citadel 1000 Tissue 
Processor with a 10 hour protocol, as outlined in Table 2. 
Table 2 
10 Hour Protocol for Tissue Processing 
SOLUTION 
50% Ethanol 
70% Ethanol 
90% Ethanol 
Absolute Ethanol 
Absolute Ethanol 
Absolute Ethanol 
Slidebright 
Slidebright 
Paraffin Wax 
Paraffin Wax 
INCUBATION TIME 
1 hour 
1 hour 
1 hour 
1 hour 
1 hour 
1 hour 
1 hour 
1 hour 
1 hour 
1 hour 
After being placed within wax in a vacuum embedder for 30 minutes, the 
tissue was embedded in paraffin wax and stored at -20'C to allow the blocks to 
harden. Sections with a thickness of 5 microns were cut using a microtome. 
Four sections from each ovary, placed on separate slides, were required - one 
for detection of Fas receptor, one for detection of Fas ligand and two for use as 
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negative controls. A section of spleen was also placed on each of the slides for 
use as a positive control. The slides were incubated at 45•c overnight to dry. 
4.3. Method 
Paraffin wax was removed from the sections using toluene, and the 
slides were then rehydrated through alcohol solutions of decreasing 
concentrations. The sections were incubated in 3% hydrogen peroxide in 
methanol for 10 minutes and washed three times in fresh PBS. 
When staining for Fas receptor, sections were first incubated in 1% 
sodium dodecyl sulphate (SDS} for 5 minutes and then washed in fresh PBS 
three times. Sections were incubated with primary antibody (mouse anti-rat 
Fas monoclonal lgG, 250pglmL} diluted 1 in 100 with PBS plus 1% bovine 
serum albumin (BSA) at room temperature for 2 hours, then washed in fresh 
PBS three times. The secondary antibody (sheep anti-mouse immunoglobulin, 
0.5mg/mL), which was diluted 1 in 100 with PBS plus 1% BSA plus 2% normal 
rat serum, was incubated on sections for 45 minutes. The slides were then 
washed in fresh PBS three times. 
When staining for Fas ligand, sections were incubated with the primary 
antibody (goat anti-rat Fas ligand polyclonallgG, 200pglmL) diluted 1 in 50 with 
PBS plus 1% BSA at room temperature for 2 hours, then washed in fresh PBS 
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three times. Sections were incubated with the secondary antibody (biotinylated 
rabbit anti-goat lgG, 1.5mg/mL) diluted 1 in 50 with PBS plus 1% BSA plus 2% 
normal rat serum for 45 minutes, then washed in fresh PBS three times. 
Streptavidin horse radish peroxidase conjugate was diluted 1 in 50 with PBS 
plus 1% BSA and incubated on sections for 45 minutes. Slides were then 
washed in fresh PBS three times. 
Negative controls for each section were treated in the same manner, but 
received diluent only in place of primary antibody. Sections of spleen were 
placed in each run as a positive control. 
All sections were then incubated for 10 minutes with 
3,3'diaminobenzidine tetrahydrochloride (DAB) solution and then washed in 
fresh PBS three times. Sections were counterstained by placing in 
haematoxylin for 6 seconds, then dehydrated through alcohol solutions of 
increasing concentrations and finally toluene. Slides were coverslipped using 
DPX mountant for viewing by light microscopy. 
See Figure 7 for experimental design. Detailed protocols are contained 
in Appendix B. 
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I 4 Rats -01 114 Rats- 08 114 Rats- 016114 Rats- 022114 Rats- PP1114 Rats -PP3j 
-• 1 Excise Left Ovary J 
! 1 Fix 24hrs in 4% Buffered Paraformaldehyde at 4°C 1 
! 1 Store in PBS at 4°C J 
~ 
1 Process Tissue and Paraffin Embed 1 
~ 
1 Cut 5 micron Tissue Sections J 
-•- .. Immunohistochemistry Immunohistochemistry 
1 o Ab: Mouse anti~rat Fas mAb 1 o Ab: Goat anti~rat Fasl pAb 
2o Ab: Biotinylated rabbit anti-goat lgG 2o Ab: Sheep anti-mouse -HRP 
3° Step: Streptavidin HRP 
• 1 Chromogen: DAB J 
+ 1 Counterstain: Haematoxylin 1 
• I Mountant: DPX I 
FIGURE 7: Experimental Design for Immunohistochemistry 
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4.4. Results 
The presence of Fas receptor and Fas ligand within the rat corpus 
luteum during pregnancy and post-partum was established using 
immunohistochemistry. 
4.4.1. Fas Receptor 
Initially, the manufacturer's recommended protocol was followed when 
staining for Fas receptor. The primary antibody was diluted 1 in 500 and 
incubation times for primary and secondary antibodies were 30 minutes each. 
Staining was not observed in any of the sections tested under these conditions. 
Dilution of the primary antibody was reduced to 1 in 100 and incubation times 
were increased to 60 minutes for the primary antibody and 45 minutes for the 
secondary antibody. Very pale staining was seen with these conditions. The 
primary antibody was then diluted 1 in 50, with incubation times remaining 
unchanged. These parameters resulted in some nonspecific staining of 
negative control sections. The incubation time was increased to two hours and 
the primary antibody was diluted 1 in 100 to alleviate nonspecific staining. Prior 
to application of primary antibody the Fas antigen was further exposed with 
treatment of 1% SDS for 5 minutes to improve stain. 
48 
Pale immunohistochemical staining indicated that the Fas receptor was 
present in the rat corpus luteum at day 1 of pregnancy. No stain was seen in 
corpora lutea of rats at days 8 and 16 of pregnancy. Whilst pale staining was 
present at day 22 of pregnancy, the stain was most intense in the corpus 
luteum at day 1 post-partum. Staining was present, but less intense, at day 3 
post-partum (see Figure 8). Within the corpus luteum, staining was 
concentrated in the cytoplasm of luteal cells. Endothelial cells displayed no 
positive staining for Fas receptor (see Figure 10). Negative control sections 
showed no nonspecific staining. Positive control sections (spleen) displayed 
scattered staining. The staining pattern and intensity in the spleen was 
consistent between immunohistochemical runs. 
4.4.2. Fas ljggnQ 
A 1 in 400 dilution of anti-rat Fas ligand polyclonal antibody with an 
incubation time of 60 minutes was initially used to localise Fas ligand, however 
no staining was seen with these conditions. Decreasing the dilution of primary 
antibody to 1 in 100 resulted in very pale staining which was unconvincing. The 
dilution of primary antibody was decreased further, to 1 in 50, but staining was 
not improved. Increasing the incubation time of the primary antibody {diluted 1 
in 50) to two hours was found to improve the staining intensity dramatically, so 
this protocol was chosen for all sections. 
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Fas ligand was present in the rat corpus luleum at all stages of 
pregnancy and post-partum examined. AI day 1 of pregnancy all but one 
corpus luteum in each rat ovary stained intensely (see Figure 12). The staining 
intensity decreased by day 8 and decreased further by day 16, with all corpora 
lutea staining positively at these stages. Expression of Fas ligand increased in 
corpora lutea at day 22 of pregnancy. Staining of Fas ligand was intense at 
day 1 post-partum and had decreased by day 3 post-partum (see Figure 11). 
Staining within the corpus luleum was seen in the cytoplasm of luteal cells. 
Endothelial cells did not stain positively for Fas ligand (see Figure 14). 
Nonspecific staining was not apparent in negative control sections. A 
characteristic scattered staining pattern was seen in the positive control 
sections of the spleen. The intensity of staining in the spleen was consistent 
between immunohistochemical runs. 
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FIGURE 8. Rat ovary sections incubated with anti-Fas mAb and stained with DAB using 
the immunoperoxidase method. Counterstained with haematoxylin. 40x. Stain 
was present at day 1 of pregnancy, but not at days 8 and 16 of pregnancy. 
Pale staining was present at day 22 of pregnancy. Intensity of stain was 
highest at day 1 post-partum and was decreasing by day 3 post-partum. The 
positive control showed scattered staining, while the negative control showed 
no nonspecific staining. (a) Day 1 of Pregnancy. (b) Day 8 of Pregnancy. (c) 
Day 16 of Pregnancy. (d) Day 22 of Pregnancy. (e) Day 1 Post-Partum. (f) 
Day 3 Post-Partum. (g) Spleen, Positive Control. (h) Day 1 Post-Partum, 
Negative Control. Arrows - Luteal Cells. Arrowheads - Endothelial Cells . 
. • 
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FIGURE 9. Stain for Fas in corpus luteum was distinct compared to the 
ovarian stroma and follicles. Rat ovary section incubated with 
anti-Fas mAb and stained with DAB using the immunoperoxidase 
method. Counterstained with haematoxylin. 10x. Day 1 Post-
Partum. CL - Corpus Luteum. S - Stroma. F - Follicle. 
FIGURE 10. Stain for Fas within the corpus luteum was isolated to the 
cytoplasm of luteal cells. Endothelial cells did not stain positively 
for Fas receptor. Rat ovary section incubated with anti-Fas mAb 
and stained with DAB using the immunoperoxidase method. 
Counterstained with haematoxylin. 1 OOx. Day 1 Post-Partum. 
Arrows - Luteal Cells. Arrowheads - Endothelial Cells. 
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FIGURE 11. Rat ovary sections incubated with anti-Fas ligand polyclonal antibody and 
stained with DAB using the immunoperoxidase method. Counterstained with 
haematoxylin. 40x. Stain was present at all stages of pregnancy and post-
partum. At day 1 of pregnancy all but one corpus luteum in each ovary stained 
intensely. The staining intensity decreased in day 8 and again in day 16 (all 
corpora lutea at these stages were stained), increasing at day 22 of pregnancy. 
Staining at day 1 post-partum was at its most intense. At day 3 post-partum 
the intensity of stain decreased slightly. The positive control showed scattered 
staining, while the negative control showed no nonspecific staining. (a) Day 1 
of Pregnancy. (b) Day 8 of Pregnancy. (c) Day 16 of Pregnancy. {d) Day 22 of 
Pregnancy. (e) Day 1 Post-Partum. (f) Day 3 Post-Partum. (g) Spleen, 
Postive Control. {h) Day 1 Post-Partum, Negative Control. Arrows - Luteal 
Cells. Arrowheads - Endothelial Cells. 
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FIGURE 12. At day 1 of pregnancy all but one corpus luteum in each rat ovary 
stained positively for Fas ligand. Rat ovary section incubated with 
anti-Fas ligand polyclonal antibody and stained with DAB using 
the immunoperoxidase method. Counterstained with 
haematoxylin. 1 Ox. Day 1 of Pregnancy. CL - Corpus Luteum. S 
- Stroma. F - Follicle. 
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FIGURE 13. Whilst staining was observed in the ovarian stroma and some 
follicles, the staining intensity was highest in corpora lutea at day 
1 post-partum. Rat ovary section incubated with anti-Fas ligand 
polyclonal antibody and stained with DAB using the 
immunoperoxidase method. Counterstained with haematoxylin. 
1 Ox. Day 1 Post-Partum. CL- Corpus Luteum. S - Stroma. F -
Follicle. 
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FIGURE 14. Within the corpus luteum, Fas ligand staining was observed within 
the cytoplasm of luteal cells. Endothelial cells displayed no 
positive staining for Fas ligand. Rat ovary section incubated with 
anti-Fas ligand polyclonal antibody and stained with DAB using 
the immunoperoxidase method. Counterstained with 
haematoxylin. 100x. Day 1 Post-Partum. Arrows - Luteal Cells. 
Arrowheads - Endothelial Cells. 
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5. RELATIVE QUANTITATIVE RT-PCR 
5.1. Rationale 
Reverse transcription-polymerase chain reaction (RT-PCR) was used to 
show the regulation of messenger RNA (mRNA) for Fas receptor and Fas 
ligand during natural regression of the rat corpus luteum. 
The expression of genes in cells or tissue is analysed by the detection of 
mRNA, as only those genes expressed by the cell will be transcribed into RNA. 
Sensitivity is an important consideration when choosing a method for the 
detection of mRNA. Procedures commonly used include Northern gels or in 
situ hybridization. These protocols require species-specific probes which were 
not available at the time of completion of this project. Our laboratory has 
recently cloned Fas and Fas ligand for rat ovaries. Thus, future studies utilising 
Northern gels and in situ hybridization may be undertaken. 
Use of the polymerase chain reaction to amplify complementary DNA 
(eDNA) produced from mRNA, a method first described by Seaburg et at in 
1986 (cited in Kawasaki, 1990, pg. 21), provides a rapid method of detection of 
mRNA with sensitivity comparable to in situ hybridization. This method, known 
as RT-PCR, involves the extraction of RNA from cells or tissue, the generation 
of eDNA by reverse transcription and amplification of eDNA by specific primers 
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using PCR. The product can be viewed by fractionating the completed PCR 
reaction on an ethidium-bromide stained agarose gel. Alternatively, PCR 
products which were radioactively labelled during the PCR reaction can be 
fractionated on an agarose gel and quantitated using autoradiography or 
phosphorimaging. 
The first step required for RT-PCR is RNA isolation, which involves 
separating RNA from other cellular contents, such as DNA and proteins. 
Tissue samples are homogenized in a commercial preparation containing 
guanidinium, such as RNAzol B. Chloroform is added to the homogenate and 
the suspension is centrifuged. RNA forms complexes wHh guanidinium and 
water molecules, whilst DNA and proteins are removed from the aqueous 
phase. The upper aqueous phase (containing RNA) is transferred to a new 
tube while the lower phases, containing DNA and proteins in chloroform, are 
discarded. RNA is precipitated by the addition of isopropanol and then 
centrifuged to form a pellet. The RNA pellet is washed with 75% ethanol, 
dessicated briefiy, resuspended in water and stored at -80'C. The 
concentration and purity of isolated RNA can be determined by 
spectrophotometric analysis. 
Isolated RNA is used to generate eDNA in a reaction catalyzed by 
reverse transcriptase. The reverse transcription reaction is initiated either with 
random hexamers, a specific downstream primer, or oligonucleotide primers 
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(oligo-dT). Primers bind to mRNA and initiate transcription of the message. 
Oligo-dT, for example, is a sequence of six thymidylates which bind to the poly 
adenylate tails of mRNA (see Figure 15). A small amount of RNA is placed in a 
PCR tube with water and primers and briefly heated at 70oC to unwind RNA. A 
mixture of the following is then added: 
• Reverse transcriptase, the enzyme which transcribes RNA into eDNA; 
• RT buffer, a buffer supplied with reverse transcriptase; 
• Deoxynucleotides (dNTPs), a mixture of the four nucleotides required for 
transcription; 
• Magnesium chloride (MgCI2), which catalyzes the reverse transcriptase 
reaction; and 
• Rnasin, which breaks down any RNases present and thus prevents RNA 
degradation. 
The reactants are incubated at 42oC for 30-60 minutes to allow RNA to be 
transcribed into eDNA (see Figure 15). The reaction is then heated to between 
70°C and 95oC for 5 to 15 minutes in order to denature the RNA-eDNA hybrid 
and to inactivate reverse transcriptase so that it will not interfere with future 
PCR reactions. The temperature of the tube is quickly dropped to 4oC and the 
reaction mix is stored at -20°C. 
mRNA 
eDNA 
s· ------AAAMA 
a· +------ II II I I (Oiigo-dT Primer) 
FIGURE 15: Reverse Transcription of RNA into eDNA 
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The eDNA obtained from reverse transcription is amplified using PCR 
technology. The following reagents are required for the PCR reaction: 
• eDNA, containing the target message to be amplified; 
• DNA polymerase, a heat-stable enzyme which replicates DNA; 
• Polymerase buffer, manufacturer's buffer supplied with DNA polymerase; 
• MgCI2 or Sodium Pyrophosphate, which catalyses the PCR reaction; 
• dNTPs, a mixture of the four nucleotides required for amplification of DNA; 
• Primers, specific primers synthesized from DNA sequences on either side of 
the required message are added to excess and serve to iniliate the 
amplification process; 
• Distilled water, as required, to increase reaction volume and dilute reagents. 
The reactants are heated to around 94 •c for a short period of time 
(approximately 4-5 minutes) to ensure that the RNA-eDNA hybrid produced by 
reverse transcription is denatured and cooled to approximately ss•c to allow 
the synthesized primers to anneal to eDNA. Heating the reaction to about 72•c 
facilitates replication of eDNA by DNA polymerase. The eDNA-DNA strand is 
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then denatured by heating to approximately 94'C and the cycles of heating and 
cooling are repeated to exponentially amplify the DNA. 
Each cycle of the PCR reaction theoretically doubles the amount of DNA 
produ~ed. For example, after one cycle two DNA strands are present, after two 
cycles four DNA strands are present, after three cycles eight DNA strands are 
present, and so on. In practice, the actual amount of DNA amplified is less 
than predicted as the efficiency of PCR reactions vary depending on the 
conditions used. The number of heating and cooling cycles chosen may range 
from 15 to 40 cycles, after taking into consideration such factors as the amount 
of message initially used, the amount of message required for the PCR reaction 
and the overall efficiency of the reaction. The concentrations of reagents and 
the temperatures and incubation times for each of the steps may influence 
reaction efficiency, therefore the PCR reaction conditions should be optimised 
for each message to be amplified. 
Depending on the initial amount of message, amplification usually runs 
at a constant efficiency of about 70-80% between cycles 15 and 30 of the 
reaction (Ferre, 1992). After a limited number of cycles the PCR reaction 
reaches a plateau phase and thereafter the amplification efficiency begins to 
decrease. Many factors, including a decrease in concentration of dNTPs or 
primers, reaction inhibition by end-products, competition for reagents by 
nonspecific products or primer-dimers, and incomplete denaturation of end-
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product, contribute to the plateau phase (Innis and Gelfand, 1990, pg. 10). 
When quantitating without internal controls in PCR, it is important to stop the 
reaction in the exponential phase, before the efficiency of the reaction becomes 
variable and the chance of nonspecific products being preferentially amplified 
increases. 
In order to quantitate the amount of DNA produced in each PCR 
reaction, a radioactively labelled nucleotide (a32P-dCTP) can be added to the 
reaction. The nucleotide is incorporated into DNA as it is synthesized and the 
radioactivity of the amplified product is quantitated. Two methods of 
quantitation were used in the present study. lri the first, unincorporated 
nucleotides were removed using isopropanol extraction and counts per minute 
of the sample obtained from a liquid scintillation counter. In the second, each 
sample was fractionated on an agarose gel (unincorporated nucleotides, 
weighing less than DNA, travel further along the gel) which was dried and 
exposed to a phosphorimaging plate. The resultant image produced by the 
radioactivity of the samples was quantitated using a computer image analysis 
program. 
The first step in making relative comparisons between the amount of 
message expressed in the rat at various stages of pregnancy and post-partum 
involved identifying a dilution factor for each time-point at which the PCR 
reaction was amplifying exponentially. Following reverse transcription, four-fold 
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serial dilutions of one sample from each time-point were amplified by PCR for a 
set number of cycles. The samples were then quantitated and the results 
plotted on a logarithmic graph (see Figure 16). . 
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FIGURE 16: Decreasing Dilutions of eDNA Plotted on a Logarithmic Scale 
Following Amplification by PCR. 
A dilution factor for each time-point was chosen where the PCR reaction 
would be amplifying exponentially when stopped. All samples were then 
amplified at the specified dilution in one PCR run. The amounts of message 
expressed at the time-points were compared relative to each other by allowing 
for the dilution factor used for the eDNA. 
Fas mRNA expression has been demonstrated in human granulosa I 
luteal cells using RT -PCR techniques (Quirk et a/, 1995), but the expression of 
Fas ligand mRNA in these cells has yet to be confirmed. The relative amounts 
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of message expressed at various stages of pregnancy and post-partum in the 
rat ovary has not previously been investigated. This information may thus 
assist in providing an insight into the function of the Fas/Fas ligand system in 
the rat ovary. 
5.2. Sample and Tissue Preparation 
The animals used for this study were:- four rats from days 1, 8 and 16 of 
pregnancy and day 3 post-partum, five rats from day 22 of pregnancy and eight 
rats from day 1 post-partum. The right ovary from each rat was dissected. 
Immediately following excision each ovary was snap frozen in liquid nitrogen 
and stored at -sooc until use. 
5.3. Method 
RNA Isolation. Whole frozen ovaries were homogenised in 1300~L 
RNAzol B. 130~L of chloroform was added and mixed and the samples were 
incubated on ice for 5 minutes. The mixtures were centrifuged at 14,000rpm for 
15 minutes. Equal volumes of isopropanol were added and mixed, and tubes 
were incubated at 4°C for one hour. The mixtures were centrifuged at 
14,000rpm for 15 minutes and the supernatants were decanted. After adding 
1mL 75% cold ethanol, the tubes were vortexed and centrifuged at 6,000rpm 
for 8 minutes. The supernatants were decanted and dessicated in a biohazard 
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cabinet for 15 minutes. The resulting pellets were resuspended in 1 0)lL of 
DMDC-treated water. The quantity and purity of the isolated RNA was 
determined using a Beckman DU-640 Spectrophotometer. 
Relative Quantitative RT-PCR for Fas Receptor. Reverse transcription 
was performed by adding 2)lL oligo-dT primer (500ng/)lL), 2)lg sample RNA 
and DMDC-treated water to a total volume of 1 0)lL Negative controls 
contained DMDC-treated water in place of RNA. The reaction mixes were 
heated to 70oC for 5 minutes and then placed on ice. A master mix of reagents 
containing 5)lL reverse transcriptase buffer (5x), 5)lL dNTPs (5mM), RNasin 
(40Ui)lL), sodium pyrophosphate (40mM) and AMV reverse transcriptase 
(23Ui)lL) was added to each tube. The reaction mixes were placed in a thermal 
cycler and incubated at 42oC for 60 minutes, heated to 95°C for 5 minutes and 
then cooled to 4°C. The eDNA was stored at -20°C. 
PCR for Fas receptor was performed by adding a master mix of reagents 
to 5)lL eDNA. Negative controls contained DMDC-treated water in place of 
eDNA The master mix contained 11 .35)lL DMDC-treated water, 2.5)lL Taq. 
polymerase buffer (10x), 4.0)lL MgCI, (25mM), 0.1)lL dATP (100mM), 0.1)lL 
dTTP (100mM), 0. 1)lL dGTP (100mM), 0.025)lL dCTP (100mM), 0.075)lL a32P-
dCTP (300mM), 1.5)lL Fas primers (2pmoli)lL, Upstream Sequence: 5' CTG 
CAG ATA TGC TGT GGA TCA 3', Downstream Sequence: 5' TTT GGT GTT 
GCT GGT TGG T 3') and 0.25)lL Taq polymerase per reaction. Reaction mixes 
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were placed in a thermal cycler and heal'd to 94'C for 4 minutes 30 seconds. 
The tubes were then incubated at 94'C for 30 seconds, 58'C for 45 seconds 
and 72'C for 1 minute and this cycle was repeated 35 times. The amplified 
samples were incubated at 72'C for 5 minutes, cooled to 4'C and stored at-
20'C. 
PCR products were fractionated on an ethidium bromide stained agarose 
gel, dried on a slab gel dryer and either exposed to x-ray film or a 
phosphorimaging plate overnight. Quantttation was performed using an image 
analysis program. Initially, four-fold serial dilutions (i.e. neat, 1/ 4 , 1/ 16, 1/ 64) of one 
sample from each lime-point were amplified by PCR, quantitated and the 
results plotted on a logarithmic graph. A dilution in the exponential phase of the 
PCR reaction was chosen for each lime-point. One PCR run with all eDNA 
samples at the specified dilution was completed and quantitated. Data from 
different time-points were compared after allowing for the dilution factor used in 
the PCR reaction. 
Relative Quantitative RT-PCR for Fas ligand. Reverse transcription was 
performed by adding 2.5~L of 3'-end primers for Fas ligand (5pmoii~L. 
Sequence: 5' AGT CTC TAG CIT ATC CAT GA 3'), t~g sample RNA and 
DMDC-treated water to make up the volume to 9~L. Negative controls 
contained DMDC-treated water in place of RNA. . Solutions were heated to 
70'C for 5 minutes. A master mix of reagents containing 5~L reverse 
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transcriptase buffer (5x), 611L dNTPs (5mM), 111L RNasin (40U/IlL), 2.51lL 
sodium pyrophosphate (40mM) and 2.51lL AMV reverse transcriptase (23U/IlL) 
was added to each tube. Reaction mixes were placed in a thermal cycler and 
incubated at 42'C for 60 minutes, heated to 95'C for 2 minutes, then cooled to 
4'C. The eDNA was stored at -20'C. 
PCR for Fas ligand was performed by adding a master mix of reagents 
to Z11L eDNA. Negative controls contained DMDC-treated water in place of 
eDNA. The master mix contained 14.351lL DMDC-treated water, 2.51lL 
PLATINUM™ Taq polymerase buffer (10x), 2.51lL MgCI, (25mM), 0.111L dATP 
(100mM), 0.1 11L dTIP (100mM), 0.111L dGTP (100mM), 0.0251lL dCTP 
(100mM), 0.0751lL o:"P-dCTP (300mM), 3.01lL Fas ligand primers (2pmollllL, 
Upstream Sequence: 5' AAA GAG GAG AAG GTC CAA CA 3', Downstream 
Sequence: 5' AGT CTC TAG CIT ATC CAT GA 3') and 0.2611L PLATINUM'" 
Taq polymerase (5.5UillL) per reaction. The reaction mixes were placed in a 
thermal cycler and heated to 94'C for 4 minutes 30 seconds. The tubes were 
then incubated at 94'C for 30 seconds, 58'C for 1 minute and 72'C for 1 
minute, and this cycle was repeated 32 times. The amplified samples were 
incubated at 72'C for 5 minutes, cooled to 4'C and stored at -20'C. 
Isopropanol extraction was used to remove unincorporated nucleotides 
from PCR products. One tenth volume of sodium acetate, pH 5.2, an equal 
volume of isopropanol and 111L glycogen were added to each tube. The 
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solutions were mixed, incubated at 4•c for 15 minutes and centrifuged at 
14,000rpm for 15 minutes. The supernatant was removed and the pellet 
washed with 500pL 70% cold ethanol and then vortexed. The samples were 
centrifuged at 14,000rpm for 5 minutes, the supernatant removed and the 
samples dessicated for 1 0-15 minutes in a biohazard cabinet. The pellets were 
resuspended in 15pL ddH,O and quantitated with a liquid scintillation counter. 
Initially, four-fold serial dilutions (i.e. neat, '14 , '1,., '1.,, '1,,.) of one sample from 
each time-point were amplified by PCR, quantitated and the results plotted on a 
logarithmic graph. A dilution in the exponential phase of the PCR reaction was 
chosen for each time-point. One PCR run with all eDNA samples at the 
specified dilution was completed and quantitated. Data from different time-
points were compared after allowing for the dilution factor used in the PCR 
reaction. 
See Figure 17 for experimental design. Detailed protocols are contained 
in Appendix B. 
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FIGURE 17: Experimental Design for Relative Quantitative RT-PCR. 
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5.4. Results 
Expression of Fas receptor and Fas ligand mRNA in the rat ovary during 
pregnancy and post-partum was analysed using a relative quantitative method 
of RT-PCR. 
5.4.1. Confirmation of mRNA Expression 
Expression of mRNA for Fas receptor and Fas ligand at the various 
stages of pregnancy and post-partum examined was confirmed by amplifying 
eDNA of one sample from each time-point by PCR. The PCR product was run 
on an ethidium-bromide stained agarose gel and viewed under UV light. Both 
Fas receptor and Fas ligand mRNA were expressed at all stages examined 
(see Figures 18 and 19 respectively). 
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491 bp 
Lane 1: Day 1 of Pregnancy 
Lane 2: Day 8 of Pregnancy 
Lane 3: Day 16 of Pregnancy 
Lane 4: Day 22 of Pregnancy 
Lane 5: Day 1 Post-Partum 
Lane 6: Day 3 Post-Partum 
Lane 7: PCR -ve Control 
Lane 8: PCR +ve Control 1 o·9 
Lane 9: 1 kb Standard Markers 
FIGURE 18: Ethidium Bromide Stained Agarose Gel from Fas Receptor RT-
PCR. Fas mRNA is expressed at each of the stages of 
pregnancy and post-partum examined. NOTE: 1.5pl of dNTPs 
(5mM) per reaction were used; a 32P-dCTP was not included; 
Samples were amplified over 38 cycles. 
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._ 341 bp 
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Lane 1: Day 1 of Pregnancy 
Lane 2: Day 8 of Pregnancy 
Lane 3: Day 16 of Pregnancy 
Lane 4: Day 22 of Pregnancy 
Lane 5: Day 1 Post-Partum 
Lane 6: Day 3 Post-Partum 
Lane 7: RT -ve Control 
Lane 8: PCR -ve Control 
Lane 9: PCR +ve Control 1 o-8 
Lane1 0:1 kb Standard Markers 
FIGURE 19: Ethidium Bromide Stained Agarose Gel from Fas Ligand RT-PCR. 
Fas ligand mRNA was expressed at each of the stages of 
pregnancy and post-partum examined. NOTE: 1.25pl of dNTPs 
(5mM) per reaction were used; a 32P-dCTP was not included; 1 pl 
of eDNA per sample was amplified; Samples were amplified over 
35 cycles_ 
5.4.2. Optimal Activity of Radionucleotide in PCR 
Samples of eDNA from day 8 of pregnancy and day 1 post-partum were 
amplified by Fas ligand PCR with varying activities of a 32P-dCTP to determine 
the optimal activity of radionucleotide to be used in future PCR reactions. The 
activities tested were OpCi, 0.1pCi, 0.25pCi, 0.5pCi and 1pCi per reaction . 
Unincorporated nucleotides were removed from the PCR products using 
isopropanol extraction and counts per minute obtained with a liquid scintillation 
counter. The results were plotted on a logarithmic graph (see Figure 20). An 
activity of 0.75pCi (0.075pl) was used in future PCR reactions. 
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FIGURE 20: PCR using Fas Ligand Primers with Varying Activities of a 32P-
dCTP per Reaction. Results at OpCi and 0.1 pCi were less than 
that of negative control and thus are not shown. 
5.4.3. Number of Cycles in Fas PCR 
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To ensure that samples would not be overamplified, four-fold serial 
dilutions of one sample from day 16 of pregnancy and one sample from day 1 
post-partum were amplified by Fas PCR either for 35 or 38 cycles. The PCR 
products were run on an agarose gel to remove unincorporated nucleotides, 
exposed to a phosphorimaging plate overnight, and quantitiated using the NIH 
image analysis program. The results were plotted on logarithmic graphs (see 
Figure 21 ). Amplification by 35 cycles was used for future Fas PCR reactions 
as the results did not show a plateau phase. At 38 cycles the reaction efficiency 
appeared to be slower and a plateau phase was evident, indicating 
overam plification. 
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FIGURE 21 : Fas PCR Using Varying Sample Dilutions Amplified by either: 
(a) 35 cycles, or (b) 38 cycles. 
5.4.4. Dilution Factors for Fas Receptor 
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A dilution factor for each time-point was chosen where the PCR reaction 
would be amplifying exponentially when stopped. This was done by making 
four-fold serial dilutions of one sample from each time-point and amplifying by 
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PCR using Fas primers. PCR products were run on an agarose gel to remove 
unincorporated nucleotides, exposed to a phosphorimaging plate overnight, 
and quantitated using the NIH image analysis program. The results were 
plotted on a logarithmic graph (refer to Figure 21 (a) for an example). All 
samples were amplifying exponenthlly after 35 cycles at a dilution of 1 in 4, 
except for day 22 of pregnancy, which was amplifying exponentially at a dilution 
of1in16. 
5.4.5. Relative Quantitative RT-PCR for Fas Receptor 
RNA samples were reverse transcribed in one run using oligo-dT 
primers. eDNA was diluted by the specified factor, and amplified by Fas PCR. 
Unincorporated nucleotides were removed by running PCR products on an 
agarose gel. The gel was dried and exposed to a phosphorimaging screen 
overnight. Samples were to be quantitated using the NIH image analysis 
program, however the quality of the phosphorimage produced was not 
adequate for quantitation. The experiment could not be repeated due to time 
constraints. 
5.4.6. Dilution Factors for Fas Ligand 
A dilution factor for each time-point was chosen where the PCR reaction 
would be amplifying exponentially when stopped. This was done by making 
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four-fold serial dilutions of one sample from each time-point and amplifying by 
PCR using Fas ligand primers. Isopropanol extraction was used to remove 
unincorporated nucleotides from PCR products and counts per minute were 
obtained with a liquid scintillation counter. The results were plotted on a 
logarithmic graph (for example see Figure 22). Samples at day 1, 8 and 16 of 
pregnancy were amplifying exponentially when not diluted (i.e. neat), whilst 
samples at day 22 of pregnancy and day 1 and 3 post-partum were amplifying 
exponentially at a dilution of 1 in 4. 
1/128 1/16 Neat 
Sample Dilution 
FIGURE 22: Fas Ligand PCR at Day 1 Post-Partum Using Varying Sample 
Dilutions to Determine Exponential Phase of Reaction. 
5.4.7. Relative Quantitative RT-PCR for Fas Ligand 
All RNA samples were reverse transcribed using 3'-end Fas ligand 
primers. eDNA was diluted if required, then amplified by Fas ligand PCR. 
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Unincorporated nucleotides were removed by isopropanol extraction and PCR 
products were quantitated by obtaining counts per minute from a liquid 
scintillation counter. The results were averaged for each of the time-points 
examined, and plotted as the fold change versus the average of day 1 of 
pregnancy (see Figure 23). 
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FIGURE 23: Expression of Fas Ligand mRNA at Various Stages of Pregnancy 
and Post-Partum in the Rat Ovary. * Significant increase 
compared to 016 values (P<O.OOS, 2-way t test) and to PP3 
values (P<O.OS, 2-way t test). 
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6. IN VITRO CORPUS LUTEUM CULTURE MODEL 
6.1. Rationale 
The discovery that spontaneous apoptosis occurs in rabbit corpora lutea 
cultured in serum-free medium led to the development of an in vitro corpus 
luteum culture model (Dharmarajan eta/, 1994). Corpora /utea functioning at 
peak levels are dissected from the ovary and cultured in serum-free medium. 
Treatments added can be assessed on the basis of their ability to reduce the 
occurrence of spontaneous apoptosis. Sridaran et a/ (1997) recently 
demonstrated that rat corpora /utea are also capable of undergoing 
spontaneous apoptosis when cultured in serum-free medium. 
Quantitation of cell death by apoptosis was determined by 3'-end 
/abe/ling of fragmented DNA. The DNA is extracted from samples with 
chloroform and isoamy/a/cohol. The 3'-ends of fragmented DNA are then 
labelled with radioactive u"P-ddATP in a reaction catalysed by terminal 
transferase. The reactinn is terminated with the addition of 
ethy/enediaminetetraacetic acid (EDTA), and labelled DNA is extracted from 
unincorporated nuc/eotides by precipitation with ammonium acetate and 
ethanol. The labelled DNA is fractionated on an agarose gel which is then 
exposed overnight to X-ray film to produce an autoradiograph. DNA 
fragmented at multiples of 180 base pair fragments, as occurs in apoptosis, will 
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show ladders in multiples of 180 base pairs on the gel, while DNA fragmented 
randomly, as occurs in necrosis, will show a smear on the gel (Tilly and Hsueh, 
1993). Low molecular weight DNA bands from each lane in the agarose gel are 
excised and counts per minute measured in a liquid scintillation counter. 
While some anti-Fas monoclonal antibodies are able to induce apoptosis 
when bound to Fas receptor (Yonehara eta/, 1989; Trauth et at, 1989), others 
are capable of blocking the receptor site and preventing transduction of an 
apoptotic signal (Oshimi eta/, 1996). In this experiment, rat corpora lutea were 
cultured in vitro in the presence of an anti-rat Fas monoclonal antibody, to 
determine if spontaneous apoptosis could be blocked via the Fas/Fas ligand 
system in luteal cells. 
Apoptosis can be induced in cultured human granulosa I luteal cells 
pretreated with interferon gamma when exposed to an anti-human Fas 
monoclonal antibody (Quirk eta/, 1995), but studies aiming to block the function 
of the Fas receptor in luteal cells have not previously been documented. 
6.2. Sample and Tissue Preparation 
Four rats from day 16 of pregnancy were required. The ovaries were 
excised and corpora lutea dissected from ovarian stroma. Two corpora /utea 
were placed in each sterile culture vial. Five vials contained 2mL of serum-free 
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medium only, five vials also contained 40~L antibody storage buffer (50% 
glycerol, 20mM NaH2P04 pH 7.5, 1.5mM NaN,, 1mg/ml BSA) and five vials 
also contained 40)ll anti-rat Fas monoclonal antibody (250)lg/ml). 
6.3. Method 
Sterile culture vials were gassed with a 95% 0 2 - 5% C02 mixture, their 
lids sealed with vacuum grease and the vials incubated at 37"C in 95% 0 2 - 5% 
CO, for 4 hours. Corpora lutea were placed in sterile polypropylene tubes, 
snap frozen in liquid nitrogen and stored at -BO'C. 
To extract DNA, each sample (consisting of two corpora lutea) was first 
homogenised in 670)ll of DNA homogenisation buffer and 42)ll 10% SDS was 
added and mixed. The tubes were incubated at 65'C for 30 minutes, then 
119)ll SM potassium acetate was added and mixed. The tubes were placed on 
ice for 60 minutes and then microcentrifuged at 5,000rpm for 10 minutes. The 
supernatant was transferred to a new tube, equal volumes of phenol: 
chloroform:isoamyl alcohol (25:24:1) were added and the tubes vortexed. The 
samples were then microcentrifuged at 6,000rpm for 5 minutes, the upper 
phase was transferred to a new tube, equal volumes of phenol: 
chloroform:isoamyl alcohol (25:24:1) were added and solutionE vortexed. The 
tubes were again microcentrifuged at 6,000rpm for 5 minutes, the upper phase 
was transferred to a new tube, 2.5x volume of cold 100% ethanol was added 
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and the reaction mix stored overnight at -80'C. The samples were 
microcentrifuged at 14,000rpm for 30 minutes and the supernatants decanted. 
The pellet was resuspended in 1 OO~L TE, pH 8.0, 2~L RNase was added and 
the solutions were vortexed, briefly microcentrifuged and then incubated at 
37'C for 60 minutes. The extraction with phenol:chloroform:isoamyl alcohol 
(25:24:1) was repeated twice and the upper phases transferred to new tubes. 
0.1x volume 3M sodium acetate and 2.5x volume cold 100% ethanol were 
added and the samples stored overnight at -80'C. Tubes were 
microcentrifuged at 14,000rpm for 30 minutes and the supernatants decanted. 
100~L cold 100% ethanol was added, tubes >•ere placed on ice for 5 minutes 
and then microcentrifuged at 14,000rpm for 5 minutes. The ethanol layer was 
decanted and the pellets air dried over a paper towel for 1-2 hours before 
resuspension in 50~L ddH20. The quantity and purity of the isolated DNA was 
established using a Beckman DU-640 Spectrophotometer, and the samples 
stored at -80'C. 
3'-end labelling was conducted on 1 ~g of DNA from each sample. A 
sample of DNA from rat corpora Jutea, immediately snap frozen after dissection 
from the ovary (time zero), was included as a baseline measurement against 
which all samples would be compared. The volumes in each tube were made 
up to 29~L with ddH,O. 10~L of terminal transferase reaction buffer (5x) and 
5~L CoCI2 were added, the tubes were vortexed and then microcentrifuged 
briefly. a"P-ddATP (3,000Ci/mmol) was diluted 1 in 8 and 5~L was added to 
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each tube. Terminal transferase was diluted 1 in 2 and l11l was added to each 
tube. The samples were vortexed, microcentrifuged briefly and incubated at 
37'C for 60 minutes. S11l 0.25M EDTA, 211L !RNA, 1211L 10M ammonium 
acetate and 18011l cold 100% ethanol were added and the tubes maintained at 
-BO'C for 60 minutes. The samples were microcentrifuged at 14,000rpm for 20 
minutes and supernatant was discarded. The pellet was resuspended in 6011l 
of 1 x TE, 121ll10M ammonium acetate and 18011l of cold 100% ethanol were 
added, the tubes vortexed and then placed at -BO'C for 60 minutes. The 
samples were microcentrifuged at 14,000rpm for 20 minutes, the supernatant 
was discarded and the pellet was air dried over a paper towel for 20 minutes. 
The pellet was resuspended in 401ll1x TE and stored at -20'C overnight. 
The samples were thawed for 20 minutes and then electrophoresed for 2 
hours 30 minutes on an agarose gel. The gel was dried on a slab gel dryer and 
exposed to X-ray film overnight. The film was developed and viewed for 
evidence of the laddering of low molecular weight DNA. Using the 
autoradiograph as a template, low molecular weight DNA from each lane was 
excised and quantitated using a liquid scintillation counter. 
See Figure 24 for experimental design. Detailed protocols are contained 
in Appendix B. 
80 
1 4 Rats at Day 16 of Pregnancy J 
~ 
I Excise Ovaries and Dissect Corpora Lutea (CL) 1 
+ + + 
4 Vials, 2 CUvial 5 Vials, 2 CUvial 5 Vials, 2 CUvial 
Serum-Free Medium Serum-Free Medium Serum-Free Medium 
+ anti-rat Fas mAb + Ab Storage Buffer Only 
• r 4 Hour Organ Culture at arc I 
~ 
( Snap Freeze CL 
• 1 Extract DNA 1 
• f 3'-End Labelling 
• Quantitate Low Molecular Weight DNA 
Using Liquid Scintillation Counter 
FIGURE 24. Experimental Design for In Vitro Corpus Luteum Culture Model. 
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6.4. Results 
6.4.1. 3'-End Labelling 
3'-Ends of extracted DNA were radioactively labelled and DNA was 
fractionated on an agarose gel. Laddering of low molecular weight DNA due to 
cleavage into 180 base pair fragments, characteristic of apoptosis, was 
identified (see Figure 25). Low molecular weight DNA was excised from each 
lane of gel and quantitated with a liquid scintillation counter (see Figure 26). 
Treatment with the antibody storage buffer demonstrated a trend in reduction in 
occurrence of spontaneous apoptosis in cultured corpora lutea. A further 
reduction in apoptosis was apparent when corpora lutea were treated with an 
anti-rat Fas monoclonal antibody in culture. The results, however, were 
variable and no significance was found. 
1 2 3 4 
Lane 1 
Lane 2 
Lane 3 
Lane 4 
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Time zero, snap frozen corpora 
lutea 
Corpora lutea cultured with 
serum-free medium only 
Corpora lutea cultured with 
antibody storage buffer 
Corpora lutea cultured with anti-
rat Fas mAb 
FIGURE 25: Autoradiograph of 3'-End Labelled DNA Extracted from Corpora 
Lutea Cultured In Vitro with Varying Treatments 
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FIGURE 26: Low Molecular Weight DNA Labelling of Corpora Lutea Cultured 
with Anti-Fas Monoclonal Antibody. 
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7. DISCUSSION 
Previous research has indicated that the Fas/Fas ligand system may 
have a role in regression of the corpus luteum (Watanabe-Fukunaga et a/, 
1992; Quirk eta!, 1995; Kondo eta/, 1996). This study examined the regulation 
of Fas receptor and Fas ligand in the rat corpus luteum during pregnancy and 
post-partum to further confirm this hypothesis. Immunohistochemistry was 
used to localise both proteins at each of the stages examined. Regulation of 
mRNA for Fas and Fas ligand was compared between stages with a relative 
quantitative method of RT-PCR. The ability of an anti-Fas monoclonal antibody 
to block the occurrence of spontaneous apoptosis in corpora lutea cultured in 
vitro with serum-free medium was also assessed. 
Whilst immunohistochemistry can be used as a quantitative technique, 
the evaluation of staining intensity can be subjective, particularly because 
staining intensity may vary between cells in any one section. Also, the results 
from different runs should not be directly compared as many factors, such as 
incubation time and ambient temperature, may affect the intensity of the stain. 
Immunohistochemistry is most effective when used to confirm the presence or 
absence of a protein and differences in staining intensity between samples in a 
single run. The variations which may be seen from run to run were countered 
by including positive controls of a tissue known to express the protein in 
question, in this case spleen. These sections were taken from a single tissue 
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block. The intensity and pattern of staining in positive control slides was 
compared to evaluate if run to run differences were of concern. 
In immunohistochemistry, it is not sufficient that the antigen under 
investigation is present in the tissue being tested - the epitope to which the 
antibody binds must be exposed for successful staining. Although the aim of 
fixation is to maintain the original structure of the·tissue, changes do occur 
during the fixation process, sometimes resulting in epitopes being concealed. 
Exposure of epitopes may be facilitated by treating the sections with agents 
such as detergents or the application of heat before the primary antibody is 
applied. For example, sections were treated with 1% SDS to expose the Fas 
antigen before treatment with the primary antibody. 
Background staining in sections is a common problem encountered 
when using immunohistochemical techniques. There are many possible 
causes for background staining, including endogenous enzyme activity, 
endogenous biotin activity, and hydrophobic or ionic binding of antibodies. A 
negative control of the same tissue treated in an identical manner except for 
application of the primary antibody (diluent only is applied) should be run for 
each section tested. Staining on the negative control section should be 
compared to that on the tissue section tested, to determine the degree of 
background staining. Appropriate steps can be taken to reduce the amount of 
background staining. For example, endogenous peroxidase activity can be 
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quenched by incubating the sections in 3% hydrogen peroxide diluted in 
methanol before application of the primary antibody. This step was used when 
staining for both Fas receptor and Fas ligand. Background staining did not 
present a problem in either case. 
When the Fas receptor is expressed on the cell surface it can be bound 
and will then transduce an apoptotic signal to the cell. Thus, it is expected that 
if the Fas/Fas ligand system is involved in cell death occurring during corpus 
luteum regression, the presence of both proteins would correlate with 
luteolysis. Fas receptor was localised in the rat corpus luteum at day 1 of 
pregnancy and days 1 and 3 post-partum. Fas ligand was present in the rat 
corpus luteum throughout pregnancy and post-partum, with 
immunohistochemical staining intensity increasing around the time of 
parturition. Thus, localisation of both proteins within the rat corpus luteum 
during luteolysis was demonstrated. 
The staining of Fas receptor observed at day 1 of pregnancy may relate 
to natural regression of corpora lutea during the normal estrus cycle of the rat. 
After formation and growth, rat corpora lutea maintain their maximum size 
through metestrus of the following cycle and then regress slowly, so that three 
or more generations of corpora lutea may be seen in the ovary (Hilliard, 1973). 
Throughout pregnancy rat corpora lutea of previous cycles grow and display 
characteristics of steroidogenic tissue (Bruce e• a/, 1984). This indicates that 
even following the onset of luteolysis, regression can be halted and corpora 
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lutea may be functional. Fas receptor is not present in the corpora lutea of 
previous estrus cycles at times of peak function in the corpus luteum of 
pregnancy. This suggests that the factor which maintains the newly formed 
corpus luteum in the rat may also positively affect the functioning of aged 
corpora lutea. Also noteworthy is the finding that Fas ligand was present in all 
but one corpus luteum in each rat ovary at day 1 of pregnancy. Further 
research will be required to ascertain if those corpora lutea which did not stain 
for the presence of Fas ligand were newly formed. 
Whilst progesterone production in the rat declines by day 22 of 
pregnancy (Waddell et a/, 1989), the weight of the corpora lutea of pregnancy 
does not fall until after parturition (Bruce et a/, 1984; Taya and Greenwald, 
1982). Fas receptor was present in corpora lutea at day 22 of pregnancy, with 
staining intensity increasing by day 1 post-partum. Thus, it is not clear if the 
Fas/Fas ligand system is involved in functional regression of the corpus luteum, 
but a role in structural regression is implicated. The weight of the corpus 
luteum of pregnancy continues to decline over numerous estrus cycles 
following parturition (Taya and Greenwald, 1982) .. Staining intensity for both 
Fas receptor and Fas ligand decreased by day 3 post-partum, although both 
proteins were still present. Further research will be required to determine 
whether Fas receptor and Fas ligand are present in the rat corpus Juteum 
throughout lactation. 
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Previous research found no evidence of vascular degeneration during 
natural regression of the pregnant rat corpus luteum (Bruce el a/, 1984). In 
agreement with this report, both Fas and Fas ligand were localised in the 
cytoplasm of luteal cells at the time of luteolysis, but staining was not observed 
in endothelial cells at any stage of pregnancy or post-partum. 
The presence of Fas ligand in rat corpora lutea throughout pregnancy 
and post-partum indicates that luteal regression may not be its only function. 
Fas ligand contributes to the immune privilege displayed by the Sertoli cells of 
the mouse testis (Bellgrau et a/, 1995) and by the mouse eye (Griffith el a/, 
1995). The ovary has also been identified as an immune privileged site 
(Streilein, 1995) and it is possible that Fas ligand has a role to play. 
Furthermore, maintenance of corpora lutea may involve mechanisms of 
immune privilege. Luteal tissue is not present at the time that the immune 
system is adapting to "self' (Bukovsky eta/, 1995) and it may be susceptible to 
immune attack. Research using gld mice (which express non-functional Fas 
ligand) is required to establish a role for Fas ligand-mediated immune privilege 
in the ovary. 
The expression of mRNA for both Fas and Fas ligand in the rat ovary 
was compared at different stages of pregnancy and post-partum using a 
relative quantitative method of RT-PCR. RT-PCR is a rapid technique and it is 
also extremely sensitive. Thus mistakes at any of the steps in the protocol can 
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produce significant errors in the final results. Further, any error will be amplified 
during the PCR step. For these reasons samples must be treated under the 
same conditions at all times anr!, if possible, be processed in a single run in 
order to reduce between-batch variability. A master mix of reagents is 
dispensed into each tube for reverse transcription and PCR reactions, so the 
concentration of reactants in each of the tubes is the same. 
One of the advantages of relative quantitative RT-PCR is that the 
synthesis of internal controls (a time-consuming exercise) is not necessary. 
However, as reverse transcription and coamplification of samples with 
exogenous internal controls is not undertaken with this method the possibility of 
varying reaction efficiencies due to well-to-wel/ variations in the thermal cycler is 
not controlled. To ensure that allowance was made for variability, at least four 
samples from each time-point were used and the results were averaged. 
Standard errors obtained for Fas ligand indicated that the results were 
reproducible. 
Another influence on reaction efficiency is the amount of message in the 
PCR tube. By making serial dilutions of one sample from each time-point to 
identify the exponential phase of the reaction, and then using that dilution factor 
for the final PCR, the amount of message in each tube is similar. Multiplying 
the result by the dilution factor used permits relative comparisons between 
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samples. The sample size (at least four for each time-point) assists in 
accounting for variations In reaction efficiency as results are averaged. 
Formation of primer-dimers in PCR reactions can create difficulties when 
quantitating results. High counts in negative controls were initially obtained 
from Fas ligand PCRs, indicating that primer-dimers were being formed. The 
occurrence of primer-dimers can be reduced by developing primers with less 
complementary sequences, using a hot start PCR method or using a Taq 
polymerase which is not activated until heated. The development of new 
primers was beyond the scope and time limitations of this project. Hot start 
PCRs, which involve adding an essential reagent to each sample tube only 
after the reactants have been heated to 94 'C (Ferre, 1 992), was not a preferrecl 
solution in this case, given that exposure to radioactivity would be increased 
and the risk of contaminating samples is high. Thus, a Taq Polymerase which 
is not activated until heated was used to reduce primer-dimers. PLATINUM'" 
Taq DNA Polymerase, supplied by Gibco BRL, is bound to an antibody which 
inhibits polymerase activity. The enzyme regains activity during the 
denaturation step at 94'C, providing an automatic hot start without the risk of 
sample contamination and ensuring that all samples receive the same amount 
of reactants. Use of this enzyme in Fas ligand PCR reduced the counts 
obtained in negative controls, indicating a reduction in primer-dlmer formation. 
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Although dilution factors for each of the time-points of the Fas PCR were 
determined by quantitating from an agarose gel using a phosphorimage, results 
for the final PCR run with all samples could not be obtained. The quality of the 
phosphorimage produced was not adequate for quantitation. It is likely that 
formation of primer-dimers influenced PCR reaction efficiency as preparation 
time was increased in the final run due to the high number of samples. Also, 
consistency in image quality appeared to vary across the phosphorimage, 
making accurate quantitation difficult. Time constraints precluded repeating 
the Fas PCR. My next step will be to repeat the PCR using PLATINUMTM Taq 
Polymerase to reduce primer-dimer formation. Quantitation will be effected by 
counts per minute following isopropanol extraction of unincorporated 
nucleotides, as this method of quantitation was effective for the Fas ligand PCR 
(as shown in Figure 23). 
The expression of Fas ligand mRNA in the rat ovary decreased slightly 
from day 1 to day 16 of pregnancy. A significant increase in expression was 
observed from day 16 to day 22 of pregnancy, just prior to parturition. This 
increase is consistent with the immunohistochemical findings and coincides 
with luteolysis. Expression appeared to decrease at day 1 post-partum, 
however the results were not significantly different from those at day 22 of 
pregnancy. The decrease in expression from day 22 of pregnancy to day 3 
post-partum was significant. In summary, Fas ligand mRNA expression 
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increases significantly at the time of luteolysis and regulation appears to follow 
a similar pattern to that seen in localisation of the protein. 
An in vitro corpus luteum culture model was used to evaluate the 
ability of an anti-Fas monoclonal antibody to block spontaneous apoptosis in 
corpora lutea placed in serum-free medium. This model does not allow 
identification of the proportion of cells undergoing apoptosis due to the loss of 
contact with surrounding cells, which may be caused by the trauma of 
dissection from the ovary. Care was taken when dissecting corpora lutea from 
the ovary and all samples were treated in the same way to reduce injury to 
cells. 
The monoclonal antibody chosen for this study was stored in a 
buffer containing 50% glycerol, a small percentage of BSA, monosodium 
phosphate and sodium azide. As the storage buffer may have influenced the 
apoptosis of luteal cells, the effect of serum-free medium with the antibody 
storage buffer alone on corpora lutea in culture was also examined. The 
results indicated that the antibody storage buffer may have reduced the 
occurrence of spontaneous apoptosis. 
The anti-Fas monoclonal antibody appeared to further reduce 
spontaneous apoptosis, although the results were not significant. More 
conclusive results may be obtained by extracting antibodies from the storage 
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buffer before culture, thus removing the possible influence of the storage 
buffer. Dose-response and time-response curves should also be produced to 
better determine how varying concentrations of antibody and increasing time 
affect spontaneous apoptosis. With these developments, the in vitro corpus 
luteum culture model should prove to be an excellent system for investigating 
the pathway(s) involved in Fas-mediated apoptosis. 
Whilst a link has been shown between the Fas/Fas ligand system 
and corpus Juteum function, it is important to remember that luteolysis is a 
mu/lifactoria/ event. Blocking the Fas receptor in vivo may not prevent 
regression of the corpus Juteum. Indeed, I am not aware of any reports of 
fertility problems in lpr or gld mice, which carry mutations in Fas receptor and 
Fas ligand respectively. 
Nonetheless, both Fas receptor and Fas ligand appear to have a role in 
corpus luteum function in the rat. As expression of both proteins increases 
during natural regression in rat pregnancy and post-partum, a role in Juteolysis 
is implicated. Future research is required in order to further define this role and 
to relate the function of the Fas/Fas ligand system to the many factors which 
influence the corpus Juteum. 
As with many studies, the results of the present project have answered 
some questions, but generated others. For example, to what extent is the 
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Fas/Fas ligand system involved in luteolysis? Is the Fas/Fas ligand system 
involved in corpus luteum regression during the normal estrus cycle of the rat? 
Are hormonal influences involved in the function of the Fas/Fas ligand system? 
Can the molecular pathway(s) involved in Fas-mediated apoptosis be 
identified? Is Fas ligand involved in immune privilege in the corpus luteum and 
ovary? With development of the in vitro corpus luteum culture model and 
utilisation of gld and lpr mice, it would appear that in future studies the answers 
to these questions will be within our reach. 
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10. APPENDIX 8- DETAILED PROTOCOLS 
1 0.1. Immunohistochemistry 
1. Paraffin wax was removed from slides following the protocol shown in 
Table 3. 
Table 3 
Protocol for Removal of Paraffin Wax from Sections 
SOLUTION 
Toluene 
Toluene 
100% Ethanol 
100% Ethanol 
70% Ethanol 
Tap Water 
Tap Water 
ACTION 
Incubate 2 minutes 
Incubate 2 minutes 
Agitate 10 times 
Agitate 10 times 
Agttate 10 times 
Agitate 10 times 
Agitate 10 times 
2. A circle was drawn around sections with a diamond pen, then slides 
w~•re placed in distilled water. 
3. Endogenous peroxidase activity was quenched by covering each section 
with 250~L 3% Hydrogen Peroxide diluted in Methanol. Slides were 
incubated in a humidified chamber at room temperature for 10 minutes. 
4. Slides were washed in fresh PBS three times for 5 minutes each time. 
5. Staining for Fas receptor: 
(a} Sections were covered with 250~L 1% SDS to expose Fas antigen. 
Slides were incubated in a humidified chamber at room temperature for 5 
minutes. 
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(b) Slides were washed in fresh PBS three times for 5 minutes each time. 
(c) The primary antibody (Mouse anti-rat Fas monoclonal lgG, 250~g/ml) 
was diluted 1 in 100 with PBS + 1% BSA. Sections on each test slide 
were covered with 250~L of diluted primary antibody. Sections on 
negative control slides were covered with 250~L PBS + 1% BSA. Slides 
were incubated in a humidified chamber at room temperature for 2 
hours. 
(d) Test slides were washed in PBS for 10 minutes. Negative control slides 
were left in the humidified chamber. All slides were then washed in fresh 
PBS twice for 10 minutes each time. 
(e) The secondary antiboay (Sheep anti-mouse immunoglobulins, 
0.5mg/ml) was diluted 1 in 100 with PBS + 1% BSA +2% normal rat 
serum (used to reduce nonspecific staining). Sections were covered 
wHh 250~L of diluted secondary antibody and incubated in a humidified 
chamber at room temperature for 45 minutes. 
6. Staining for Fas ligand: 
(a) The primary antibody (Goat anti-rat Fas ligand polyclonal lgG, 
200~g/ml) was diluted 1 in 50 with PBS + 1% BSA. Sections on each 
test slide were covered with 250~L of diluted primary antibody. Sections 
on negative control slides were covered with 25011L PBS + 1% BSA. 
Slides were incubated in a humidified chamber at room temperature for 2 
hours. 
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(b) Test slides were washed in PBS for 10 minutes. Negative control slides 
were left in the humidified chamber. All slides were then washed in fresh 
PBS twice for 10 minutes each time. 
(c) The secondary antibody (Biotinylated rabbit anti-goat lgG, 1.5mg/ml) 
was diluted 1 in 50 with PBS + 1% BSA + 2% normal rat serum. 
Sections were covered with 250~l of diluted secondary antibody and 
incubated in a humidified chamber at room temperature for 45 minutes. 
(d) Slides were washed in fresh PBS three times for 5 minutes each time. 
(e) Streptavidin Horse Radish Peroxidase (HRP) conjugate was diluted 1 in 
50 with PBS + 1% BSA. Sections were covered with 250~l of diluted 
Streptavidin-HRP and incubated in a humidified chamber at room 
temperature tor 45 minutes. 
7. Staining for both Fas receptor and Fas ligand: 
Slides were washed in fresh PBS three times for 5 minutes each time. 
8. 1 ml of 1 Ox DAB was added to 9ml PBS. Just before use 5.5~l of 
Hydrogen Peroxide was added to the DAB solution. 
9. Each section was covered with 500~l DAB solution. Slides were 
incubated in a humidified chamber at room temperature for 10 minutes. 
10. Slides were washed by dipping in fresh PBS once, then by placing in 
fresh PBS twice for 5 minutes each time. 
11. Sections were counterstained with Haematoxylin and dehydrated 
following the protocol shown in Table 4. 
Table4 
Protocol for Counterstaining and Dehydrating Sections 
SOLUTION 
Haematoxylin 
Tap Water wash 
Tap Water wash 
70% Ethanol 
1 00% Ethanol 
100% Ethanol 
100% Ethanol 
100% Ethanol 
Toluene 
Toluene 
Toluene 
ACTION 
Incubate 2 seconds 
Agitate 10 times 
Agitate 1 0 times 
Agitate 1 0 times 
Agitate 1 0 times 
Agitate 10 times 
Agitate 10 times 
Agitate 10 times 
Agitate 1 0 times 
Agitate 1 0 times 
Agitate 1 0 times 
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12. Slides were coverslipped using DPX Mountant, then viewed by light 
microscopy. 
1 0.2. Relative Quantitative RT-PCR 
RNA Extraction - RNAzol B Method 
1. Homogeniser probe was placed in Dimethyldicarbonate (DMDC)-treated 
water for one hour to destroy any RNases present. 
2. Tissue was kept on ice until ready to homogenise. 
3. 650~L of RNAzol B was added to each ovary before homogenising. A 
further 650~L of RNAzol B was added to each tube and ovaries were 
again homogenised briefly. Homogeniser probe was rinsed in DMDC-
treated water between samples. 
4. 130~L of Chloroform was added to each tube and mixtures were shaken 
vigorously for 15 seconds. 
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5. Tubes were incubated on ice for 5 minutes. 
6. Solutions were transferred to 2ml eppendorf tubes and centrifuged at 
14,000rpm for 15 minutes. 
7. The upper aqueous phase of each tube was transferred to a new 2ml 
eppendorftube and an equal volume of Isopropanol was added. 
8. Tubes were mixed, then incubated at 4"C for one hour. 
9. Tubes were centrifuged at 14,000rpm for 15 minutes. 
10. Solutions were decanted with care taken not to lose pellet. 
11. 1 ml of 75% cold Ethanol was added to each tube and solutions were 
vortexed briefly. 
12. Tubes were centrifuged at 6,000rpm for 8 minutes. 
13. Solutions were decanted. A pipette was used to remove excess 
solution. 
14. Pellets were dried by placing open eppendorf tubes in a biohazard 
cabinet for 15 minutes. 
15. Pellets were resuspended in 1 O~L of DMDC-treated water. 
16. Quantitation and purity of isolated RNA was established with a Beckman 
DU-640 Spectrophotometer. 
Reverse Transcription Using Oligo-dT Primer 
1. 2~L ofOiigo-dT Primer, 500ng/~L was placed in each tube. 
2. 2~g of sample RNA was added to each tube. A negative control without 
RNA was placed in each run. 
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3. The volume in each tube was made up to 1 Opl with DMDC-treated 
water. 
4. Tubes were placed in thermal cycler and incubated at ?o·c for 5 
minutes, then placed on ice. 
5. 15pl of a master mix of reagents was added to ,;ach tube. 
Reverse Transcription Master Mix (A), 1x 
Reverse Transcriptase Buffer (5x) 5pl 
dNTPs (5mM) 5pl 
RNasin (40U/pl) 1pl 
Sodium Pyrophosphate (40mM) 2.5pl 
AMV Reverse Transcriptase (23U/pl) 1.5pl 
6. Sample tubes were placed in thermal cycler on the following program: 
(a) 42•c for 60 minutes 
(b) 95•c for 5 minutes 
(c)4•c 7. 
7. eDNA was stored at -2o•c. 
Reverse Transcription Using Synthesized 3'-End Primers for Fas Ligand 
1. 2.5pl of 3'-end primers for Fas ligand, 5pmol/pl was placed in each 
tube. 
2. 1 pg of sample RNA was added to each tube. A negative control without 
RNA was placed in each run. 
3. The volume in each tube was made up to 9pl with DMDC-treated water. 
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4. Tubes were placed in thermal cycler and incubated at 70'C for 5 
minutes. 
5. 16pl of a master mix of reagents was added to each tube. 
Reverse Transcription Master Mix (B). 1x 
Reverse Transcriptase Buffer (5x) 5pl 
dNTPs (5mM) 5pl 
RNasin (40U/pl) 1 pl 
Sodium Pyrophosphate (40mM) 2.5pl 
AMV Reverse Transcriptase (23U/pl) 2.5pl 
6. Sample tubes were placed in thermal cycler on the following program: 
(a) 42'C for 60 minutes 
(b) 95'C for 2 minutes 
(c) 4'C 7. 
7. eDNA was stored at -20'C. 
PCR Using Fas Primers 
1. 5pl of eDNA from each sample was amplified. A negative control 
substituting DMDC-treated water for eDNA an·d a positive control (diluted 
10·', developed in the Molecular Biology Laboratory, Dept. of Anatomy 
and Human Biology, University of Western Australia) were placed in 
each run. 
2. 20pl of a master mix of reagents was added to the eDNA in each tube. 
PCR Master Mix (A), 1x 
DMDC-Treated Water 11 .35~L 
Taq Polymerase Buffer (10x) 2.5~L 
MgCI2 (25mM) 4.0~L 
dATP (100mM) 0. 1~L 
dGTP (1 OOmM) 0.1~L 
dTIP (100mM) 0. 1~L 
dCTP (1 OOmM) 0.025~L 
a32P-dCTP (300mM) 0.075~L 
Fas Primers (2pmoi/~L) 1.5~L 
Taq Polymerase (5.5U/~L) 0.25~L 
3. Sample tubes were placed in thennal cycler on the following program: 
(a) 94oc for 4 minutes 30 seconds 
(b) 94°C for 30 seconds 
(c) 58°C for 45 seconds 
(d) 72°C for 1 minute 
(e) Steps (b) to (d) were repeated 35 times 
(f) noc for 5 minutes 
(g) 4°C 7. 
4. Amplified samples were stored at -20°C. 
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PCR Using Fas Ligand Primers 
1. 2pl of eDNA from each sample was amplified. A negative control 
substituting DMDC-treated water for eDNA and a positive control (diluted 
1o·•, developed in Molecular Biology Laboratory, Dept. of Anatomy and 
Human Biology, University of Western Australia) was placed in each run. 
2. 20pl of a master mix of reagents was added to the eDNA in each tube. 
PCR Master Mix (B), 1x 
DMDC-Treated Water 
PLATINUM'" Taq Polymerase Buffer (10x) 
MgCI2 (25mM) 
dATP (100mM) 
dGTP (1 OOmM) 
dTIP (100mM) 
dCTP (1 OOmM) 
u32P.<JCTP (300mM) 
Fas Ligand Primers (2pmol/pl) 
Taq Polymerase (5.5U/pl) 
14.35pl 
2.5pL 
2.5pL 
0.1pL 
0.1pl 
0.1pl 
0.025pl 
0.075pL 
3.0pL 
. 0.25pL 
3. Sample tubes were placed in a thermal cycler on the following program: 
(a) 94'C for 4 minutes 30 seconds 
(b) 94'C for 30 seconds 
(c) 58'C for 1 minute 
(d) 72'C for 1 minute 
(e) Steps (b) to (d) were repeated 32times 
(f) 72"C for 5 minutes 
(g) 4"C 7. 
4. Amplified samples were stored at-20"C. 
Isopropanol Extraction of Unincorporated Nucleotides from PCR Products 
1. 18~L of PCR product was placed into a clean eppendorf tube. 
2. 1.8~L 3M Sodium Acetate, pH 5.2, was added. 
3. 20~L Isopropanol was added and solution was mixed. 
4. 1~L Glycogen was added. 
5. Samples were incubated at4"C for 10 minutes. 
6. Samples were centrifuged at14,000rpm for 15 minutes. 
7. Supernatant was removed. 
8. Pellet was washed with 500~L 70% cold Ethanol, then vortexed. 
9. Samples were centrifuged at14,000rpm for 5 minutes. 
10. Supernatant was removed. 
11. Samples were dessicated for 10-15 minutes in a biohazard cabinet. 
12. Pellet was resuspended in 15~L ddH,O. 
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Running an Agarose Gel to Remove Unincorporated Nucleotides from PCR 
Products 
1. Ends of a gel tray were sealed with autoclave tape and a comb placed 
with the shorter edge of wells facing forward. 
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2. 6~L Ethidium Bromide per 100ml of a 1.5% Agarose in 1x TAE solution 
was added and mixed without creating bubbles. 
3. Agarose gel was poured into gel tray without creating bubbles and gel 
was allowed to harden for about 10 minutes. 
4. 1x TAE was poured into electrophoresis chamber. 
5. Gel tray, with tape removed, was placed in electrophoresis chamber. 
6. Gel was just covered with 1 x TAE. 
7. One drop of 6x Loading Dye was placed onto a sheet of parafilm. 
8. 4~L of PCR product was mixed with loading dye using a pipette, then 
loaded into well. 
9. Steps 7 and 8 were repeated for each sample. 
1 u. 2~L of 1kb Standard with loading dye was used as a marker for each 
run. 
11. Gel was run at 70 - 80 volts for 35 minutes. 
12. The gel was viewed under UV light. The Fas PCR product was 491 
base pairs and the Fas ligand PCR product was 341 base pairs. 
13. Gel was placed on two pieces of blotting paper, which were cut so that 
the edges extended 2 - 3 em around the gel. 
14. Gel and blotting paper were covered loosely in plastic wrap and dried in 
a vacuum slab gel dryer for about 1 hour. 
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15. The radioactive gel was either exposed to x-ray film in an autoradiograph 
cassette at -BO'C overnight, then developed, or exposed to a 
phosphorimaging plate at room temperature overnight, then quantitated 
using an image analysis computer program. 
Relative Quantitative RT-PCR for Fas mRNA 
1. One sample from each time-point was reverse transcribed using the 
protocol titled "Reverse Transcription Using Oligo-<JT Primer". 
2. Four-fold serial dilutions (i.e. neat, 1/ 4, 1/ 16 , 1/ 04) of each sample were 
amplified by PCR using the protocol titled "PCR Using Fas Primers". 
3. Amplified products were run on an agarose gel and dried using the 
protocol tilled "Running an Agarose Gel to Remove Unincorporated 
Nucleotides from PCR Products", then quantitated after exposure to a 
phosphorilnaging plate. 
4. Results were plotted on a logarithmic graph and a dilution amplifying 
exponentially when the PCR reaction was stopped was chosen for each 
time-point. 
5. All samples were reverse transcribed in the one run using the protocol 
titled "Reverse Transcription Using Oligo-dT Primer". 
6. The eDNA of all samples was diluted to the factor chosen. 
7. All samples were amplified by PCR in one run using the protocol titled 
"PCR Using Fas Primers". 
118 
8. Amplified products were run on one agarose gel using the protocol titled 
"Running an Agarose Gel to Remove Unincorporated Nucleotides from 
PCR Products", then quantitated after exposure to a phosphorimaging 
plate. 
9. Data from different time-points was compared after allowing for the 
dilution factor used in the PCR reaction. 
Relative Quantitative RT-PCR for Fas Ligand mRNA 
1. One sample from each time-point was reverse transcribed using the 
protocol titled "Reverse Transcription Using Synthesized 3' -End Primers 
for Fas Ligand". 
2. Four-fold serial dilutions (I.e. neat, 1/ 4 , 'I,., '164 , 1/ 128) of each sample were 
amplified by PCR using the protocol titled "PCR Using Fas Ligand 
Primers". 
3. The protocol titled "Isopropanol Extraction of Unincorporated Nucleotides 
from PCR products" was followed and samples were quantitated with a 
liquid scintillation counter. 
4. Results were plotted on a logarithmic graph and a dilution amplifying 
exponentially when the PCR was stopped was chosen for each time-
point. 
5. All samples were reverse transcribed in one run using the protocol titled 
"Reverse Transcription Using Synthesized 3'-End Primers for Fas 
Ligand". 
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6. The eDNA of all samples was diluted to the factor chosen. 
7. All samples were amplified by PCR in one run using the protocol titled 
"PCR Using Fas Ligand Primers". 
8. Amplified products were purified of unincorporated nucleotides using the 
protocol titled "Isopropanol Extraction of Unincorporated Nucleotides 
from PCR Products", then quantitated with a liquid scintillation counter. 
9. Data from different time-points was comr 6red after allowing for the 
dilution factor used in the PCR reaction. 
10.3. In Vitro Corpus Luteum Culture Model 
Corpus Luteum In Vitro Cultyre Model 
1. Four sterile scintillation vials were prepared by adding 2ml serum-free 
minimal essential medium (MEM) with 1 ~g/ml (a total of 40~L) anti-rat 
Fas monoclonal antibody. Another five sterile scintillation vials were 
prepared with the addition of 2ml serum-free MEM and 40~L of antibody 
storage buffer (50% glycerol, 20mM NaH2P04 pH 7.5, 1.5mM NaN,, 
1 mg/ml BSA). Serum-free MEM only was added to a further five sterile 
scintillation vials. 
2. Two corpora lutea were placed in each vial. 
3. The vials were gassed with a 95% 0 2 - 5% C02 mixture and their lids 
sealed with vacuum grease. 
4. Vials were incubated under 95% 0 2 - 5% CO, at 37'C for 4 hours. 
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5. Corpora lutea were placed in sterile polypropylene tubes and snap 
frozen in liquid nitrogen. 
6. Samples were stored at -ao·c. 
DNA Extraction 
1. Each sample (consisting of two corpora lutea) was gently homogenised 
in 670~L of DNA homogenisation buffer. 
2. Homogenate was transferred to a 2ml eppendorf tube and 42~L of 10% 
SDS was added and mixed. 
3. Tubes were incubated at 55•c for 30 minutes. 
4. 119~L BM Potassium Acetate was added and mixed. 
5. Tubes were incubated on Ice for 60 minutes. 
6. Tubes were microcentrifuged at 5,000rpm for 10 minutes. 
7. Supernatant was transferred to new tubes and divided in half. 
8. Equal volumes of Phenoi:Chloroform:lsoamyl alcohol (25:24:1) were 
added to each tube and the solution was vortexed. 
9. Tubes were microcentrifuged at 6,000rpm for 5 minutes. 
10. The upper phase was transferred to a new tube. 
11. Equal volumes of Phenoi:Chloroform:lsoamyl alcohol (25:24:1) were 
added to each tube and the solutions were vortexed. 
12. Tubes were microcentrifuged at 6,000rpm for 5 minutes. 
13. The upper phase was transferred to a new tube. 
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14. 2.5x volume of cold 100% Ethanol was added and tubes were stored 
overnight at -80"C. 
15. Tubes were microcentrifuged at 14,000rpm for 30 minutes. 
16. Solutions were decanted, while taking care not to lose pellet. 
17. 100pl 1x TE, pH 8.0, was added and the pellet was resuspended. 
18. 2pl RNase was added and r.olutions were vortexed. 
19. Tubes were microcentrifuged briefly, then incubated at 37"C for 60 
minutes. 
20. Steps 7 to 12 were repeated. 
21. The upper phase was transferred to a new tube. 
22. 0.1x volume 3M Sodium Acetate and 2.5x volume cold 100% Ethanol 
was added and tubes were incubated at -80"C overnight. 
23. Tubes were microcentrifuged at 14,000rpm for 30 minutes. 
24. Solutions were decanted, taking care not to lose pellet. 
25. 100pl cold 100% Ethanol was added without disrupting pellet. 
26. Tubes were placed on ice for 5 minutes, then centrifuged at 14,000rpm 
for 5 minutes. 
27. Ethanol was decanted w~hout disrupting pellet, then tubes were inverted 
over a paper towel to allow pellet to air dry for approximately 1 to 2 
hours. 
28. Pellet was resuspended in 50pl ddH,O. 
29. Quantitation and purity of isolated DNA was established with a Beckman 
DU-640 Spectrophotometer. 
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30. Samples were stored at -SO'C. 
3'-End Labelling 
1. 1 pg of each DNA sample was placed into eppendorf tubes. A sample of 
DNA from rat corpora lutea which were immediately snap frozen after 
dissection from the ovary (time zero) was included to be used as a 
baseline measurement against which all samples would be compared. 
2. Volumes were made up to a total of 29pl with ddH20. 
3. 10pl of 5x Terminal Transferase Reaction Buffer was added. 
4. 5pl of CoCI, was added, then tubes were vortexed well. 
5. Tubes were microcentrifuged at 14,000rpm for 10 seconds. 
6. a32P-ddATP (3,000 Ci/mmol) was diluted 1 in 8 and 5pl was added to 
each tube. 
7. Terminal transferase was diluted 1 in 2 and 1pl was added to each tube. 
8. Tubes were vortexed, then microcentrifuged at 14,000rpm for 10 
seconds. 
9. Tubes were incubated at 37'C for 60 minutes. 
10. 5pl 0.25M EDTA was added. 
11. 2pl !RNA solution was added. 
12. 12pl 10M Ammonium Acetate was added. 
13. 180pl cold 100% Ethanol was added. 
14. Tubes were placed in -SO'C for 60 minutes. 
15. Tubes were microcentrifuged at 14,000rpm for 20 minutes. 
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16. Supernatant was discarded. 
17. Pellet was resuspended in 60~L of 1x TE. 
18. 12~L 10M Ammonium Acetate was added. 
19. 180~L of cold 100% Ethanol was added. 
20. Tubes were vortexed, then placed in -ao•c for 60 minutes. 
21. Tubes were microcentrifuged at 14,000rpm for 20 minutes. 
22. Supernatant was discarded. 
23. Pellet was inverted over paper towel and allowed to air dry for 20 
minutes. 
24. Pellet was resuspended in 40~L 1x TE and stored at -2o•c overnight. 
25. Samples were thawed for 30 minutes. 
26. Ends of a gel tray were sealed with autoclave tape and a comb placed at 
one end. 
27. A 2% Agarose in 1x TAE gel was prepared, poured into the gel tray 
without creating bubbles and allowed to set. 
28. 1x TAE was poured into an electrophoresis chamber. 
29. Gel tray, with tape and comb removed, was placed into electrophoresis 
chamber and gel was just covered with 1 x TAE. 
30. Samples were vortexed, then microcentrifuged at 14,000rpm for 10 
seconds. 
31. S~L of DNA loading buffer was added to each sample. 
32. Samples were votexed, then microcentrifuged at 14,000rpm for 10 
seconds. 
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33. 20~L of each sample was loaded into a well. The remaining volume of 
each sample was stored at -20°C. 
34. Samples were electrophoresed at 50 volts for 2 hours 30 minutes. 
35. The gel was removed and placed onto two pieces of blotting paper, 
which were cut so that the edges extended 2 - 3 em around the gel. 
36. Gel and blotting paper were covered loosely in plastic wrap and dried in 
a vacuum slab gel dryer for 3 hours. 
37. Blotting paper was removed from gel and gel was covered with a new 
piece of plastic wrap. 
38. The radioactive gel was taped inside an autoradiograph cassette and 
exposed to X-ray film at -sooc overnight. 
39. The film was developed, viewed for laddering of low molecular weight 
DNA, then placed under the gel in its original position. 
40. Each lane was marked using the autoradiograph as a guide. 
41. Low molecular weight DNA from each lane was excised using a scalpel, 
then placed in a scintillation vial. 
42. The counts per minute of low molecular weight DNA for each sample 
was obtained with a liquid scintillation counter. 
11. APPENDIX C -SOLUTIONS AND BUFFERS 
1.5% Aqarose Gel plus 1x TAE 
Aqarose 
1xTAE 
1.5g 
100ml 
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Place agarose in TAE and heat in microwave on medium setting until dissolved. 
3,3'Diaminobenzidine Tetrahydrochloride (DAB), 10X 
DAB 120mg 
PBS 10ml 
Dissolve DAB in PBS. Store in 1 ml aliquots in freezer. 
NB: DAB is carcinogenic. Use a biohazard cabinet and wear gloves and a 
face mask when weighing out powder. Neutralise any item which 
contacts powder or solution with 1 in 10 dilution of bleach after use. 
Dimethyldicarbonate (DMDC) Treated Water 
Add one part DMDC to 1000 parts double distilled water (ddH20). Autoclave 
solution. 
DNA Homogentsation Buffer 
NaC11M 
EDTA 0.5M, pH 8.0 
Tris 1M, pH 8.0 
Sucrose 1M 
Make up solution to 500mL by adding 190ml ddH,O. 
DNA Loading Buffer 
Glycerol (v:v) 
Bromophenol Blue (w:v) 
Xylene Cylanol (w:v) 
In Vitro Culture Mediurr 
Minimal Essential Medium (Gibco}, 1x 
(with Earle's salts, without L-glutamine, 
without Phenol red) 
Bovine Albumin, fatty acid free 
L-glutamine, powdered 
Sterile filter, then add: 
Penicillin (5000U/ml) 
Streptomycin (5000J1g/ml) 
Store at 4 •c. 
50ml 
10ml 
150ml 
100ml 
30% 
0.25% 
0.25% 
100ml 
100mg 
29.2mg 
200lll 
200lll 
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4% Paraformaldehyde 
Sodium Phosphate Buffer, pH 7.2 100ml 
Paraformaldehyde Powder 4g 
Heat 50ml sodium phosphate buffer to BO'C. Add 4g paraformaldehyde and 
dissolve with constant stirring. Add NaOH drop by drop until solution clears. 
Cool solution and make up to 1 OOml with sodium phosphate buffer. Use fresh 
solution. 
NB: Paraformaldehyde is a possible mutagen, teratogen and carcinogen. 
Use a biohazard cabinet and wear gloves and a face mask when weighing out 
powder and preparing solution. 
Phosphate Buffered Saline (PBS) 
NaCI 
KCI 
Na2HP04 
KH,PO, 
MgCI, 
CaCI2 
B.Og 
0.2g 
1.6g 
0.2g 
0.1g 
0.1g 
Dissolve salts individually in the order given in approximately 800ml of ddH,O. 
Make up solution to 1 litre with ddH,O and adjust to pH 7.4 with NaOH. Use 
fresh solution or autoclave before storage. 
PBS plus 1% Bovine Serym Albumin (PBS + 1% BSAl 
PBS 
BSA 
100ml 
1g 
Dissolve BSA in PBS. Store aliquots at -20°C. Keep at 4°C when thawed. 
Sodium Phosphate Buffer, pH 7.2 
1M Na,HPO, 
1M Na,H2PO, 
Make solution up to 1 litre with ddH20. 
TAE Buffer, 10x 
Tris 
Glacial Acetic Acid 
O.SM EDTA, pH 8.0 
Make solution up to 1 litre with ddH,O. 
TE, 1x 
1M Tris-HCI, pH 8.0 
O.SM EDTA, pH 8.0 
68.4ml 
31.6ml 
. 48.4g 
11.4ml 
20ml 
5ml 
1ml 
Make up solution to 500ml by adding 494ml ddH20. 
Tris-HCI 
Use HCI to buffer Trizma Base to the required pH. 
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12. APPENDIX D- SUPPLIERS 
12.1. Reagents 
Reagent 
u32P-dCTP 
u32P-ddATP 
Agarose 
Ammonium acetate 
AMV reverse transcriptase 
Anti-rat Fas monoclonal antibody 
Anti-rat FasL polyclonal antibody 
Biotinylated rabbit anti-goat lgG 
Bovine serum albumin 
Bromophenol Blue 
Calcium chloride (CaCI,) 
Chloroform 
Cobalt chloride (CoCI,) 
dATP 
dCTP 
dGTP 
Supplier 
DuPont, USA 
Amersham Life Science, UK 
Pharmacia Biotech, Sweden 
Sigma, USA 
Promega, USA 
Transduction Laboratories, UK 
Santa Cruz Biotechnology, USA 
Vector Laboratories, USA 
Sigma, USA 
Sigma, USA 
Sigma, USA 
Sigma, USA 
Boehringer Mannheim, Germany 
Promega, USA 
Promega, USA 
Promega, USA 
Diaminobenzedine tetrahydrochloride (DAB) Sigma, USA 
Disodium hydrogen phosphate (Na,HPO,) BDH, Australia 
DMDC Sigma, USA 
DPX mountant 
dTTP 
Ethanol 
Ethidium bromide 
Ethylenediaminetetraacetic Acid (EDTA) 
Glacial Acetic Acid 
Glycerol 
Glycogen 
Haematoxylin 
Hydrogen peroxide 
lsoamylalchohol 
Isopropanol 
L-glutamine 
Magnesium chloride (MgCI,) 
Methanol 
Minimal essential medium (MEM) 
0/igo-dT primers 
Paraffin wax 
Paraformaldahyde powder 
Penicillin 
Phenol 
PLATINUMTM Taq polymerase 
Potassium acetate 
Potassium chloride (KCI) 
BDH, Australia 
Promega, USA 
BDH, Australia 
Sigma, USA 
Sigma, USA 
BDH, Australia 
Sigma, USA 
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Boehringer Mannheim, Germany 
Australian Biostain, Australia 
Sigma, USA 
Sigma, USA 
Sigma, USA 
Sigma, USA 
Sigma, USA 
BDH, Australia 
Gibco BRL, USA 
Promega, USA 
Oxford Labware, USA 
Merck, Germany 
ICN Pharmaceuticals, USA 
Sigma, USA 
Gibco BRL, USA 
Sigma, USA 
Ajax Chemicals, Australia 
Potassium dihydrogen orthophosphate 
(KH,P04) 
Reverse transcriptase buffer 
RNasin 
RNAzol B 
Sheep anti-mouse immunoglobulins 
Sodium acetate 
Sodium azide (NaN,) 
Sodium chloride (NaCI) 
Sodium dihydrogen orthophosphate 
(NaH,P04) 
Sodium dodecyl sulfate (SDS) 
Sodium pyrophosphate 
Strepavidin HRP 
Streptomycin 
Taq polymerase 
Taq polymerase buffer 
Terminal transferase reaction buffer 
Toluene 
Trizma Base 
!RNA 
Xylene Cylanol 
Ajax Chemicals, Australia 
Promega, USA 
Promega, USA 
Bresatec, Australia 
Amersham Life Science, UK 
Sigma, USA 
Sigma, USA 
BDH, Australia 
BDH, Australia 
Sigma, USA 
Sigma, USA 
Amersham Life Science, UK 
ICN Pharmaceuticals, USA 
Gibco BRL, USA 
Gibco 'BRL, USA 
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Boehringer Mannheim, Germany 
BDH, Australia 
Sigma, USA 
Boehringer Mannheim, Germany 
Sigma, USA 
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12.2. Equipment 
Equipment Supplier 
Audioradiograph Cassette Kodak Scientific, Australia 
Beckman DU-640 Spectrophotometer Beckman Instruments Inc., USA 
Incubator Contherm Scientific Co., NZ 
Gel Electrophoresis Apparatus, Easy Owl Scientific, Australia 
Cast#B2 
Mini-Gel Electrophoresis Apparatus Pharmacia, Sweden 
Incubator, Water jacketed, model 3157 Forma Scientific, USA 
Light Microscope, Leitz Wetzler Henderson Instrument Co., Australia 
Liquid Scintillation Counter, Tri-Carb Packard Laboratory Services, 
Australia 
Microcentifuge, 5415C Eppendorf, Germany 
Programmable Thermal Controller, MJ Research Inc., USA 
PTC-100 
P10, P200 and P1000 Pippettes, Biohit Locus Genex, Finland 
Proline 
Phosphorimager, Mac Bas 1000 
Bioimaging Analyser 
Power Supply Module, 216A 
Tissue Processor, Citadel 1000 
Slab-gel dryer, Uniequip 3040 
Fuji Photofilm Co. Ltd., Japan 
BWD Electronics, Australia 
Shandon Upshaw, USA 
Lab Supply, Australia 
Spencer 820 Microtome 
Ultra-Turrax Homogeniser Probe 
Vaccuum Embedder 
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American Optical Corporation, USA 
IKA®-Werk, Janke and Kunkel 
GmbH & Co .. , Germany 
Labec Laboratory Equipment, 
Australia 
Vortex Mixer- 16700 Mixer Thermolyne Barnstead Thermolyne, USA 
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13. CONFERENCE ABSTRACT 
Abstract accepted to the Combined Biological Sciences Meeting, August, 1997 
in Fremanlle, W.A.: 
ROLE OF FAS AND FAS LIGAND IN APOPTOSIS DURING LUTEOLYSIS 
S. Roughton, A. Oharmarajan• and A. Bittles 
Dept of Human Biology, Edith Cowan University, Joondalup, Westem Australia 6027 
*Dept of Anatomy and Human Biology, University ofW.A., Nedlands, Western Australia 6009 
Whilst apoptosis has been found to occur during structural regression of the corpus luteum (1), 
the mechanisms involved have yet to be specified. One possible mediator is the Fas (or AP0-1 
or CD95) receptor, a transmembrane protein which induces apoptosis in the cell when ligated. 
As the Fas receptor is expressed in the regressing corpus luteum (CL} of the normal adult 
human ovary (2), and Fas monoclonal antibodies induce apoptosis in cultured human granulosa 
and luteal cells pretreated with interferon gamma (3), we hypothesized that the mechanism of 
regression of the CL may involve Fas-mediated apoptosis. Th~ presence of Fas and Fas ligand 
(FasL) in the rat CL at various stages of pregnancy and post-partum was examined 
immunohistochemically. Steady state Fas and FasL mRNA levels in the rat ovary at various 
stages of pregnancy and post-partum were analysed by semi-quantitative RT-PCR. The FasL 
protein was localised in the rat CL throughout pregnancy and post-partum. In addition, mRNA 
for Fasl was expressed at each time-point examined. The Fas receptor protein was localised in 
the rat CL at one day post-partum, a period when the CL is undergoing maximal apoptosls. 
Studies to date indicate that the Fas I Fasl system has a role in apoptosis during luteolysls. 
Further investigations into the mechanisms of Fas-mediated CL apoptosis are currently being 
undertaken. 
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